NEWSpublisher 2007 :: AngloChinese Investments
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
»24/05/2010 [Industry news]
China Biotech to 24th May 2010

Details on recent industry activities...   more»

»24/05/2010 [Other]
See New EVENT NOV 2010 in Events Listing

...   more»

»21/05/2010 [Independent reports]
Progress in China medical reform over the past year

The Chinese government unveiled a three-year plan for health care reform, involving an investment of at least 850 billion yuan, in April 2009. During the past year, the reform has brought significant changes to public health care services....   more»

»21/05/2010 [Industry news]
Chindex International Inc will expand its network of hospitals

The company is looking to grow “wherever there are significant urban centers” in China, Alan Kahn, vice president for marketing at the Bethesda, Maryland-based company, told reporters today. Chindex held a ceremony with Commerce Secretary Gary Locke to showcase its new health center in Beijing, China’s first oncology clinic....   more»

»21/05/2010 [Industry news]
Chiltern announces new offices in APAC

Chiltern International, a global contract research organisation (CRO) has announced its expansion plans in Asia Pacific....   more»

GlaxoSmithKline »19/05/2010 [Industry news]
GlaxoSmithKline Makes Aggressive Play for Emerging Markets

(Bloomberg): Because GlaxoSmithKline (GSK) wants to double its China and India revenues by 2015, the company will significantly reduce its prices – as much as 70% – to raise revenues. The company readily admits it is trailing its multinational rivals such as Pfizer (PFE) and Sanofi-Aventis (SNY) in developing markets. Abbas Hussain, President of Emerging Markets for Glaxo, said in an interview with Bloomberg News...   more»

»19/05/2010 [Industry news]
Tasly Pharmaceutical and TRANSGENE Form JV

Tianjin Tasly Pharmaceutical Co. Ltd., the leading traditional Chinese medicine (TCM) manufacturer, announced on May 18 that it will set up a joint venture (JV) with French company Transgene SA Ltd. for the development of biological drugs....   more»

»19/05/2010 [Industry news]
i3 Acquires ChinaGate,

i3 Acquires ChinaGate, Providing Customers with Greater, More Efficient Access to Chinese Market i3, a global life sciences services company and subsidiary of Ingenix, has acquired ChinaGate, a contract research organisation (CRO) that provides product-development regulatory services for pharmaceutical, medical device and biotechnology companies looking to enter and access the Chinese market....   more»

»18/05/2010 [Industry news]
OriGene Technologies, Inc. To Build The World Largest TrueMAB Monoclonal Antibody Facility In Wuxi, China

...   more»

»18/05/2010 [Finance]
Skystar Bio-Pharmaceutical (CGPN) Reports 27% Growth in Revenue From Continuing Operations in First Quarter Fiscal Year 2010

Revenue increases 27% YoY to $4.9 million...   more»

»17/05/2010 [Industry news]
A week in Review - to 17th May 2010

A snapshot of activities within the bio industry over the past week...   more»

Simcere Pharmaceutical Group »17/05/2010 [Company watch]
Simcere Wants to Sell OTC Division, Add Prescription Drug Partnerships

...   more»

3SBIO (Shenyang Sunshine) »17/05/2010 [Finance]
3SBio Inc. (SSRX) Announces Unaudited First Quarter 2010 Results

Total net revenues increased by 40.5% over the first quarter of 2009 to RMB96.4 million (US$14.1 million)....   more»

Roche »16/05/2010 [Company watch]
Roche Diagnostics Growing at 50% Rate in China

Roche Diagnostics has been experiencing annual revenue increases of close to 50% per year, and the company expects the large increases to continue, driven by the PRC’s investment into healthcare. Roche Diagnostics thinks China will soon become its fifth largest market, up from eighth last year....   more»

»15/05/2010 [Other]
Two pharmacy firms punished for producing substandard rabies vaccines

Two pharmacy firms were punished for producing 210,000 doses of substandard human rabies vaccines, said the State Food and Drug Administration (SFDA) here Saturday....   more»

Johnson & Johnson
»14/05/2010 [Company watch]
Johnson & Johnson Creates R&D Centre with Tianjin Cancer Hospital

Johnson & Johnson Pharmaceutical Research Group will join Tianjin Medical University Cancer Hospital to build a Joint R&D Center in Oncology, which will be housed at the Tianjin Cancer Hospital....   more»

»14/05/2010 [Other]
Where will China-Britain relations go?

As Tory leader David Cameron entered 10 Downing Street on May 11, Britain\\\'s first coalition government under parliament since 1974 was finally formed. We had some political skirmishes between China and UK during Gordon Brown\\\'s term. In addition to disagreements over human rights and Darfur, the two sides traded barbs over emission reduction and tariff barriers....   more»

»14/05/2010 [Industry news]
Genzyme ties up with Tianjin Academy of Biotechnology

The Tianjin International Joint Academy of Biotechnology and Medicine (TJAB) and Genzyme Corporation have joined hands for a research partnership....   more»

Wuxi Pharma Tech
»13/05/2010 [Company watch]
WuXi PharmaTech Reports Strong Q1 Revenues

WuXi PharmaTech reported Q1 revenues rose 36% to $80.6 million, helped by a very large increase in its contract manufacturing division, which grew 433% to $13.6 million. In WuXi’s core Lab Services business, revenues were up 18%. GAAP net income climbed 32% to $15.5 million or 21 cents per share....   more»

»13/05/2010 [Industry news]
PAREXEL International Strengthens Leading Presence in the Asia/Pacific Region With Two New Locations in China

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that the Company has opened offices in Chengdu and Guangzhou, China to support a growing requirement for a broad range of clinical development and regulatory consulting capabilities in the country and throughout the Asia/Pacific region....   more»

»13/05/2010 [Industry news]
Chinese expert seeks to kill HIV with another virus

The idea doesn\'t sound complicated: Make one virus able to kill another....   more»

Merck & Co
»13/05/2010 [Industry news]
Emerging markets key for Merck long-term performance

Merck & Co has highlighted emerging markets such as China and Latin America as a major driver for its success over the next few years. They will be a key contributor to our long-term performance, said president Kenneth Frazier in the company’s first R&D briefing since its merger with Schering-Plough last November....   more»

»12/05/2010 [Industry news]
Skystar Bio-Pharmaceutical (CGPN) Commences Testing on Two Additional New Product Dosage Forms to Further Expand the Company Product Lines

Skystar Bio-Pharmaceutical Company announced that it will commence product testing of two additional product dosage forms: oral solution and injectable soluble powder specifically formulated for Skystar veterinary line of medicines....   more»

»11/05/2010 [Industry news]
MediGene Continues the Global Licensure of Veregen

The biotech company MediGene has signed two further license and supply agreements for the commercialization and marketing of Veregen®. These have been signed with GC-Rise Pharmaceutical Co., Ltd. in China and JS Bio Pharm Co., Ltd. in South Korea....   more»

»11/05/2010 [Other]
China drug regulator to rein in chaotic health food market

China drug regulator has introduced a plan to clamp down on the nation\'s unruly health food market....   more»

»10/05/2010 [Other]
Carbon tax likely, expert forecasts

China may start levying a carbon tax and further boost prices of fossil fuel for the next five years as a crucial incentive to cut greenhouse gas emissions and help realize green targets, a government-affiliated expert forecast...   more»

»10/05/2010 [Industry news]
A week in review to 9th May 2010

industry activities in the past week...   more»

»07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd

The Department of Health (DH) today (May 7) directed licensed drug manufacturer Quality Pharmaceutical Laboratory Ltd to recall all its products from the market in view of further quality defects on analysis of its products....   more»

»06/05/2010 [Industry news]
Drug maker debut lands China\'s new richest man

A pharmaceutical researcher once spurned by big state-owned firms became China\'s richest man on Thursday after shares in a drug maker partly owned by Goldman Sachs (GS.N) were listed in the southern boomtown of Shenzhen....   more»

»06/05/2010 [Industry news]
Hepalink defies China market gloom on debut

While the rest of the Chinese stock market dropped more than 4 per cent on Wednesday, the most talked about initial public offering of the month managed a surge of 18.4 per cent on its trading debut,...   more»

»05/05/2010 [Other]
China Heart-Disease Surge Poses Major Crisis, Study Finds

Smoking, dietary changes and sedentary lifestyles are stoking a surge in heart disease and stroke in China that will kill an additional 7.7 million people over the next two decades, posing a major crisis, a study found....   more»

»05/05/2010 [Industry news]
China Medicine appoints CFO, nominates directors

China Medicine Corporation, a manufacturer, distributor and developer of pharmaceuticals, traditional Chinese medicines (TCMs), and nutraceuticals, appointed Mr Fred Wai-Kuen Cheung as its Chief Financial Officer....   more»

»04/05/2010 [Other]
China\'s industrial profit more than doubled in Q1

Industrial enterprises in China\'s 24 regions reported combined profits of 690.8 billion yuan ($101.2 billion) in the first quarter, more than double the figure of the same period last year, the National Bureau of Statistics (NBS) said in a statement Wednesday....   more»

»04/05/2010 [Industry news]
China FDA Officials Arrested On Bribery Charge

According to Beijing Youth Daily, five officials from China State Food and Drug Administration have been arrested for allegedly accepting bribes....   more»

»04/05/2010 [Industry news]
BIO 2010: Taiwan unveils $1.9 bn biotech fund

Organized by Taiwan’s Industrial Technology Research Institute, Dr. Jin-Fu Chang, Minister of State of the Executive Yuan, and Dr. Johnsee Lee, President of Taiwan BIO Industry Organization unveiled the availability of $ 1.9 billion venture fund, during 2010 Bio Convention held in Chicago....   more»

»03/05/2010 [Industry news]
The Week in Review: CROs Consolidating

Industry news in the last week...   more»

Charles River
»02/05/2010 [Company watch]
Charles River Goes Global With Largest Ever Foreign Takeover of Chinese Company

Clinical research group Charles River (CRL) is expanding its Asian footprint with a $1.6 billion purchase of WuXi PharmaTech (WX), a key player in China\'s thriving drug development market. It will be the largest foreign takeover of a Chinese company, according to Bloomberg....   more»

Lotus Pharmaceuticals »30/04/2010 [Company watch]
Lotus Pharma to commence asthma drug trial in China

Lotus Pharmaceuticals, a developer, manufacturer and seller of pharma products in China, reported that its asthma drug Laevo-Bambuterol has received approval to conduct clinical trials from China\'s State Food and Drug Administration (SFDA)....   more»

»30/04/2010 [Independent reports]
Pharma Prospects: A billion reasons to invest in China

China is the most populous country on earth with 1.3 billion inhabitants. These people are the reason why China is fast becoming a super power. This is a problem of plenty, as the government needs to provide healthcare to all and providing these many people with adequate healthcare is a task in itself. Here are the factors that beckon pharma companies to China....   more»

»29/04/2010 [Company watch]
AlphaRx Canada to Merge with Pacific Orient

AlphaRx, Inc. announced that its newly formed China subsidiary, AlphaRx Canada, signed a non-binding letter of intent to execute a reverse merger with Pacific Orient Capital, listed on the Toronto Venture Exchange. The new company, which will be known as Pacific Orient Biopharma Group, will focus on branded generic drug development and distribution in China as well as other emerging markets....   more»

»29/04/2010 [Company watch]
China Pediatric Reports Reverse Merger, 2009 Results

China Pediatric Reports Reverse Merger, 2009 Results China Pediatric Pharmaceuticals, Inc. (CPDU.OB), which completed its reverse merger in October 2009, said its revenues rose 14% in 2009 to $16.7 million, though net income declined slightly to $2.5 million. The company ended its fiscal year with $900,000 in cash. Its only operating entity is Shaanxi Jiali Pharmaceutical Co., Ltd., headquartered in Xi’an....   more»

»29/04/2010 [Company watch]
China Medical Announces New ECLIA Analyzer

China Medical Technologies, Inc. (the \"Company\") (CMED), a leading China-based advanced in-vitro diagnostic (\"IVD\") company, today announced that it received approval for its AUTOMAGLIA 90 fully-automated ECLIA analyzer (\"AUTOMAGLIA 90 Analyzer\") as well as Down Syndrome screening kit (\"Down Syndrome Screening\") from the State Food and Drug Administration of China (the \"SFDA\")....   more»

»28/04/2010 [Company watch]
China Biologic Eligible for Provincial R&D Financial Support

China Biologic Products, Inc., which has been rolling up plasma-based companies in China, said its Shandong Taibang Biological Products subsidiary was named one of twelve model Shandong-based biopharmaceutical companies. The honor, which was conferred by the Shandong provincial government, makes Shandong Taibang eligible for financial subsidies and tax concessions to support new drug R&D....   more»

Bayer »27/04/2010 [Company watch]
Bayer Reports $709 Million in 2009 China Revenues

Bayer AG (BAYRY.PK) said its China revenues in 2009 totaled $709 million, a 28% increase from the year earlier. This means the company met its yearly goal of beating the 20% growth of China’s pharma market last year. To help meet that target in the future, Bayer expects to introduce 20 new products over the next five years. The average of four new drugs per year is slightly better than 2009, when it completed three launches....   more»

»26/04/2010 [Industry news]
The Week in Review: Innovation

Industry news in the past week...   more»

Charles River »26/04/2010 [Company watch]
Charles River and Wuxi Pharmatch to Combine, Creating the First Global CRO Offering Fully Integrated Early-Stage Drug Development Service

Charles River Laboratories International, Inc. (NYSE: CRL), a leading global provider of research models and associated services and of preclinical drug development services, and WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading drug research and development outsourcing company with expertise in discovery chemistry and with operations in China and the United States, today announced that they have signed a definitive agreement under which Charles River and WuXi will combine in a cash and stock transaction valued at approximately $1.6 billion....   more»

»26/04/2010 [Company watch]
PPD Opens Vaccine Research Center in Taizhou

PPD, announced it has opened a vaccine clinical research center in Taizhou, China, further strengthening its clinical research and development services in one of the country’s major regions for conducting vaccine studies. Through the center, PPD will provide clinical monitoring services to global and local biopharmaceutical companies seeking to develop vaccines in China....   more»

China Aoxing Pharmaceutical Company, Inc. »26/04/2010 []
Aoxing andJohnson Matthey Announce China JV for Narcotic APIs

Aoxing Pharmaceutical Company Inc. today announced that Aoxing Pharma and Johnson Matthey Plc have entered into an agreement to establish a joint venture through affiliated companies focused on research, development, manufacturing and marketing of active pharmaceutical ingredients (\"API\') for narcotics and neurological drugs for the China market....   more»

»24/04/2010 [Other]
Winners Announced for First SEED Business Plan Competition in China

Dr. Yuqiang Wang from Guangzhou Jinan University College of Pharmacy was declared the winner of the SEED Life Sciences Business Plan Competition. Dr. Josen Ma, from Pharminova Bio-tech Co. Ltd. and Dr. Bai Xu from Suzhou Natong Bionanotechnology Co. Ltd. were named as the runners-up....   more»

»23/04/2010 [Company watch]
Kun Run Biotech Raises $8 Million from OrbiMed

Kun Run Biotechnology, Inc. (the \"Company\" or \"Kun Run\") (OTC Bulletin Board: KURU), a leading bio-pharmaceutical company in China that focuses on manufacturing and sales of peptides, peptide-based drugs and small molecule drugs, today announced the signing of a private placement agreement totaling approximately US$8 million of preferred stock and warrants with Caduceus Asia Partners, L.P., an investment fund managed by OrbiMed Advisors, LLC, and Mr. Xueyun Cui, the Chairman of the Company\'s Board of Directors and the majority stockholder of the Company...   more»

»23/04/2010 [Company watch]
NeoStem and ImmuneRegen to Collaborate on Stem Cells

NeoStem and ImmuneRegen BioSciences have announced a collaborative research agreement, which focuses on the development of an advanced, adult human stem cell product....   more»

»22/04/2010 [Company watch]
ATS Medical Reports Use of Recently Approved Heart Valve

ATS Medical, Inc. (NSDQ: ATSI) reported the first commercial implant of the ATS 3f® Aortic Bioprosthesis, a tissue valve, was completed recently at Fu Wai Hospital in Beijing, China. ATS Medical, of Plymouth, Minnesota, received SFDA approval of the valve last month. ATS Medical maintains an office in Shanghai....   more»

Sanofi-Aventis »22/04/2010 [Company watch]
Sanofi Aventis: Deeply Committed to China

Sanofi-Aventis (NYSE: SNY) recently announced it has established a regional R&D center in Shanghai. Unlike many of its big pharma competitors, Sanofi-Aventis is not building a lab and hiring scores of scientists to work exclusively on S-A projects. Instead, the company is focused on developing collaborations, a strategy that allows it to build on China’s innovative biopharma culture....   more»

Simcere Pharmaceutical Group »22/04/2010 [Company watch]
Simcere Pharma Moves Closer to International Sales with Approval for Diarrhea Drug

Simcere Pharma (NYSE: SCR) reported that diosmectite, the API in its branded generic diarrhea drug Biqi, has passed EU-GMP inspection. Diosmectite is made from a natural mineral, and Simcere owns a high-grade diosmectite mine in China. It is the leading anti-diarrhea drug in China and France....   more»

»21/04/2010 [Company watch]
Lotus Pharmaceuticals\' Innovative Drug to Receive SFDA Fast Track Approval

Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) (\"Lotus\" or the \"Company\"), a growing developer, manufacturer and seller of medicine and drugs in the People\'s Republic of China (the \"PRC\") reported that its asthma drug Laevo-Bambutero will receive the China\'s State Food & Drug Administration\'s (SFDA) Fast Track Approval to enter clinical trials....   more»

»20/04/2010 [Company watch]
Artepharm Global to Market TCM-Based Malaria Drug

Artepharm Global Corp. (OTCBB: ARGC) formed a joint venture with a similarly named China company, Artepharm Co. Ltd. (Artepharm China), to market a malaria drug. Artepharm China is a Guangzhou based biopharma whose malaria drug, Artequick®, produced $1.5 million of revenue in 2009....   more»

»19/04/2010 [Other]
Chinese shares plummet nearly 5% over tightening moves

The Chinese stock market saw the biggest daily fall in eight months Monday, with Shanghai key index closing lower than 3,000....   more»

»19/04/2010 [Independent reports]
Special Report: Chuang Yang Huang: Asian expenditure on healthcare to rise

Dr Chung Yang Huang President, Nature Wise Biotech & Medicals Corporation, Taiwan Singapore, Apr 19, 2010: The major trends in life sciences industry include rapid growth of per capita health expenditure in Asia Pacific countries especially in China and India increasing the demand prospect of the industry...   more»

»19/04/2010 [Other]
New Event VacChina 2010 Vaccine Development Summit

15th/16th Sept...   more»

»18/04/2010 [Finance]
China likely to revalue week of May 10:

China is likely to revalue its currency early next month, possibly during the week of May 10, as the Shanghai 2010 Expo gets underway, after months of internal debate on its currency appears to be nearing consensus, according to Standard Chartered Bank....   more»

»15/04/2010 [Other]
Greenpeace worries GM rice about to be planted

Genetically modified rice seeds, along with some rice and rice products, have been on sale in Hunan and Hubei provinces, Greenpeace China claimed during a press conference on Wednesday. Local food authorities said investigations are underway....   more»

»15/04/2010 [Industry news]
SpectralWorks Announces Distributor For China

SpectralWorks Limited has entered into a distribution agreement with Labcare Scientific Group of China ( )....   more»

Charles River
»15/04/2010 [Company watch]
Charles River Shanghai preclinical facility receives Belgian GLP cert

Charles River Shanghai Receives OECD Certification. First preclinical contract research organization in China to receive certification...   more»

»14/04/2010 [Other]
U.S. health insurer seeks to set up JV in China

The U.S. health benefits provider Wellpoint Inc sought to set up a health insurance firm in China, the China Daily reported Wednesday....   more»

»14/04/2010 [Industry news]
Radient Pharma Set to Sell China Subsidiary

Radient Pharmaceuticals currently expects prospective purchasers of its China subsidiary, Jade Pharmaceutical, Inc. to complete their due diligence by the end of May 2010....   more»

China Aoxing Pharmaceutical Company, Inc. »14/04/2010 [Company watch]
China Aoxing Pharmaceutical Corp. Approved to List on NYSE AMEX

Aoxing Pharmaceutical Company, Inc, a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, today announced that it received authorisation to list its common stock on the NYSE AMEX market....   more»

»12/04/2010 [Other]
China forex reserves rise to 2.45 trillion USD

China foreign exchange reserves hit a new high of US$2.4471 trillion by the end of March, up 25.25 percent year on year, the People\'s Bank of China (PBOC), the central bank, announced Monday. (Xinhua)...   more»

»12/04/2010 [Industry news]
AB SCIEX Launches New Application Support Centre to Help Advance Life Science Innovation in China

AB SCIEX, a global leader in life science analytical technologies, today announced the formal opening of its Asia Pacific Application Support Centre in Shanghai....   more»

»12/04/2010 [Industry news]
Radient Pharmaceuticals Monetizing China-Based Jade Pharmaceutical

US-based pharmaceutical company Radient Pharmaceuticals Corporation announced today it anticipates prospective purchasers or financiers will complete due diligence for RPC\'s China-based subsidiary Jade Pharmaceutical, Inc. by the end of May 2010....   more»

»12/04/2010 [Independent reports]
Forecast 2015: The Next BIG trends

The pharmaceutical industry in the last few years has adapted various strategies like shifting R&D focus, reorganizing business units, outsourcing manufacturing and R&D, and retrenchment of employees to improve productivity....   more»

»12/04/2010 [Industry news]
Sanofi Aventis opens regional R&D centre in Shanghai

French pharma giant Sanofi-Aventis has launched its first regional research and development centre in Shanghai in China....   more»

»11/04/2010 [Industry news]
China Bio Industry - a week of activities

Industry news...   more»

»11/04/2010 [Industry news]
Tongjitang Receives Buyout Offer From CEO and Fosun

Tongjitang Chinese Medicines Company has received a buy-out offer from a JV comprised of Mr. Xiaochun Wang, who is the company Chairman and CEO, and Fosun Industrial, the Hong Kong conglomerate....   more»

»08/04/2010 [Company watch]
Sinovac Provides Colour to Strong 2009 Results

The Beijing biopharma whose flu vaccines suddenly became very profitable in the second half of last year, released its 2009 financial results this week....   more»

»08/04/2010 [Industry news]
MicuRx, Cumencor, Pfizer to discover TB drugs in China

Three companies have come together to discover therapeutic agents to treat multidrug resistant TB in China....   more»

»07/04/2010 [Industry news]
ICON And Tigermed Sign Alliance Agreement in China

ICON , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries and Tigermed Consulting, a leader in the provision of clinical drug development services in China, today announced that they have signed an alliance agreement....   more»

AstraZeneca »06/04/2010 [Company watch]
Werum Software installs PAS-X MES at AstraZeneca\'s Wuxi site

Lueneburg, Germany based Manufacturing Execution System (MES) software provider Werum Software & Systems has successfully finalized the installation of PAS-X MES in AstraZeneca\'s Wuxi site in the Jiangsu Province, China....   more»

»06/04/2010 [Company watch]
China Yongxin Pharmaceuticals Reports Increase in net Income for 2009

China Yongxin Pharmaceuticals, Inc. a fast-growing vertically-integrated health products company in China, announced today its financial results for the fourth quarter and for the year ended December 31, 2009....   more»

»06/04/2010 [Industry news]
Neostem: Chinese Subsidiary Gains Approval for Antibiotic

NeoStem, Inc. reported that its China subsidiary, Suzhou Erye Pharma, was granted SFDA approval to produce cloxacillin sodium API, a generic anti-infective....   more»

Simcere Pharmaceutical Group »05/04/2010 [Company watch]
Operations of Simceres Latest Acquisition Remain Shut Down

Simcere Pharmaceutical Group reported that a recent acquisition, Jiangsu Yanshen Biological Technology, committed fraud with respect to its human-use rabies vaccine. Simcere bought a controlling interest in Jiangsu Yanshen in October 2009 and shut down its operations just one month later. As soon as Simcere found out about the problem, it urged Jiangsu Yanshen’s board to cease operations and review the company s quality control....   more»

»04/04/2010 [Industry news]
China Bio Industry News

A week of activities in the China Bio/Pharm Sector...   more»

»04/04/2010 [Other]
Gates Foundation expects novel ideas from Chinese talents

A global health program launched by Bill & Melinda Gates Foundation is expecting to hear and provide fund for creative ideas of researchers worldwide, including those from China....   more»

»03/04/2010 [Other]
Google Hong Kong Web Site Changes Its Logo

(Bloomberg) -- Google Inc. Chinese name, a symbol of its presence in China since 2006, has been dropped from its Hong Kong web site, less than a week after the U.S. company blamed China’s government-controlled firewall for causing a service disruption....   more»

»02/04/2010 [Industry news]
China plans to train 300,000 general practitioners

China will train up to 300,000 general practitioners within 10 years to satisfy the needs of primary-level medical and health care institutions, Xinhua News Agency reported Friday....   more»

»01/04/2010 [Company watch]
China Baicaotang Reports Strong Fourth Quarter and Full Year 2009 Results

China Baicaotang Reports Strong Fourth Quarter and Full Year 2009 Results Full Year 2009 Revenue Increases 25% to $136.1 Million Full Year 2009 Net Income Rose 17% to $19.4 Million, or $0.61 Per Diluted Share...   more»

»01/04/2010 [Industry news]
Teijin, Astellas join hands for Chinese market

Japanese pharma companies, Teijin Pharma and the two subsidiaries of Astellas, namely Astellas Pharma China and Astellas Pharma Hong Kong, have entered into an agreement regarding the marketing of TMX-67 (febuxostat) in China and Hong Kong respectively....   more»

»01/04/2010 [Industry news]
China Pharma Completes Reverse Merger

China Pharmaceuticals, Inc. has completed a reverse merger with Allstar Restaurants. Effective March 30, 2010, the company’s name officially changed and it began trading under its new symbol....   more»

»01/04/2010 [Other]
U.S. researchers develop new method to detect melamine in milk

Researchers at the University of Miami have developed a fast, economical and easy method to detect melamine in milk. The new method was described in a study published online this week by the journal Applied Physics Letters....   more»

»31/03/2010 [Industry news]
Cord Blood America Signs License Agreement To Operate Stem Cell Collection Business In China

Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company ( ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has signed a License and Cooperation Agreement for the processing and storage of umbilical cord blood in China with AXM Pharma, Inc....   more»

Eli Lilly & Co »30/03/2010 [Industry news]
Eli Lilly to invest aggressively in China

Eli Lilly to launch 15 new products in China in 5 yrs...   more»

»30/03/2010 [Company watch]
Quintiles, Inc. Global Central Lab in China Earns Prestigious National Award

RESEARCH TRIANGLE PARK, N.C.--Quintiles’ Global Central Laboratory in China has won the national “Best Central Lab 2009” award from Shanghai Mental Health Centre....   more»

»29/03/2010 [Industry news]
Industry News

A brief view of business in the past week...   more»

»29/03/2010 [Industry news]
Qiagen establishes sponsored professorship in USTC

The sponsorship agreement has a term of 10 years and will create a full-time professor position at USTC in the field of life sciences....   more»

»29/03/2010 [Independent reports]
Asias spectacular rise create serious challenges

Asia spectacular rise—and bright prospects for growth—have created some serious challenges for governments in the region, not least of which are the needs to adapt to changing disease profiles and rapidly ageing populations,” said Mr Charles Goddard, Editorial Director, Asia-Pacific, Economist Intelligence Unit....   more»

»29/03/2010 [Industry news]
Sinovac Biotech Ltd. Enters Exclusive Supply and Distribution Agreements with Parenteral Biotech Ltd. for India

Sinovac Biotech Ltd. , a China-based vaccine manufacturer, announced today it has entered into exclusive license, supply and distribution agreements with Parenteral Biotech Ltd., a subsidiary of Parenteral Drugs (India), Ltd., an India-based pharmaceutical company. Pursuant to the agreements, Parenteral is authorized to register, supply and distribute Sinovac\'s Anflu (seasonal influenza vaccine) and PANFLU.1 (H1N1 vaccine) to the government of India and private market in India. Currently, the registration process is ongoing in India....   more»

»29/03/2010 [Industry news]
Dragon Pharmaceuticals Inc. to Go Private for $0.82/Share

Dragon Pharmaceutical Inc. announced today that it has entered into a definitive merger agreement to be acquired by Chief Respect Limited, a Hong Kong corporation, which is a newly created entity controlled by Dragon Pharma\'s Chairman and Chief Executive Officer, Yanlin Han...   more»

»29/03/2010 [Other]
Verdict of Rio Tinto trial handed down in Shanghai

Four defendants in the Rio Tinto case, including Australian national Stern Hu, got jail terms from seven to 14 years for bribery and stealing commercial secrets, court sources said Monday....   more»

»29/03/2010 [Industry news]
Milestone Scientific issues corporate update

Milestone is currently working in concert with its Chinese distribution partner, China National Medicines...   more»

»26/03/2010 [Other]
Scientists make genetically-modified cow with high Omega-3 fatty acid level

The world\'s first genetically-modified cow with high level of Omega-3 fatty acid is nine-months old, healthy and expected to produce milk rich in the fatty acid essential for human health, Chinese scientists said Friday....   more»

»25/03/2010 [Other]
China Tops India on World Diabetes Ladder as Boom Spurs Obesity

China has overtaken India as the global epicenter of the diabetes epidemic after a study showed twice as many Chinese are afflicted with the disease as previously estimated....   more»

»25/03/2010 [Industry news]
Beijing establishes medical dispute resolution committee

hospitals that have been involved in too many disputes which have ended poorly will be penalized, according to March 24....   more»

»24/03/2010 [Industry news]
New national drug price list to include all NRDL and NEDL products

The National Development and Reform Commission (NDRC) recently issued the Category of Pricing Drugs from the NDRC, which will go into effect April 1...   more»

»23/03/2010 [Industry news]
Simcere succeeds in Endostar phase IV study

Chinese company Simcere Pharmaceutical announced that it has successfully completed Endostar phase IV clinical study at a conference in Beijing dedicated to this study....   more»

China Sky One Medical,Inc. »23/03/2010 [Company watch]
China Sky One to launch 13 products in six months

China Sky One Medical said that it will be launching 13 new, SFDA approved, products over the next few quarters...   more»

»22/03/2010 [Finance]
China Accuses U.S. of Politicizing Yuan as Trade Surplus Sinks

China warned the U.S. against imposing sanctions over the value of the yuan, arguing that the exchange rate issue has been politicized and that a rise in protectionism threatens the global economic recovery....   more»

»22/03/2010 [Industry news]
Matrix, PharmaVentures sign MoU

Matrix Corporate Capital and PharmaVentures announced the signing of a Memorandum of Understanding covering strategic transactions in the biotech, pharmaceutical and med tech sectors....   more»

»22/03/2010 [Industry news]
Over 150 healthcare leaders to identify priorities for reform in Asia

Economist Conferences’ Healthcare in Asia roundtable will be held in Singapore on March 30 and 31, bringing together over 150 of the region’s foremost healthcare experts including health ministers, regulators, policymakers, leading practitioners and academics....   more»

»22/03/2010 [Other]
Google May Leave China by April 10

Google decision to cease its operation in China is edging closer to reality after months of negotiations. China Business News reports that Google plans to leave China on April 10....   more»

»21/03/2010 [Industry news]
China Offers Lion Share of Emerging Market Growth

IMS Health has upped its count of “pharmerging” countries to 17 high-growth pharmaceutical markets....   more»

»21/03/2010 [Industry news]
Sinovac Finds India Partner for H1N1 Vaccine

Sinovac Biotech Co. has signed up Parenteral Drugs India to distribute its H1N1 Influenza Vaccine (Split Virion) and Inactivated (Panflu.1) in India. Parenteral, which will have an exclusive license for the vaccines in India, will presumably be responsible for registering them in its home territory....   more»

China Sky One Medical,Inc. »19/03/2010 [Industry news]
China recognizes Antroquinonol as Breakthrough Drug

China Sky One Medical announced that Antroquinonol (Hocena) capsule, a new anti-cancer drug co-developed with Taiwan Golden Biotechnology was recognized as Breakthrough Drug by the Chinese Ministry of Science and Technology....   more»

China Sky One Medical,Inc. »19/03/2010 [Company watch]
China Sky One Medical expects 2010 revenues to grow by 20% to $156 million.

Net income, however, will increase by a more modest 13% to $39 million, as the company ups its R&D to 15% of revenue. At the same time, the company said it will shift its corporate focus to cardiovascular medicine and antibiotic drugs....   more»

China Sky One Medical,Inc. »18/03/2010 [Industry news]
China Sky One Medical, Inc. Announces Antroquinonol Capsule Recognized as Breakthrough Drug by Chinese Ministry of Science and Technology

China Sky One Medical, today announced that Antroquinonol (Hocena) capsule, a new anti-cancer drug co-developed by Taiwan Golden Biotechnology Corporation was recognised as Breakthrough Drug by the Chinese Ministry of Science and Technology....   more»

»17/03/2010 [Company watch]
Novartis China: Spectacular Climb in 2009

Novartis AG , the Swiss multinational pharma, said revenues in China grew 36% last year...   more»

»17/03/2010 [Company watch]
American Oriental Marginal Beat

American Oriental Bioengineering fourth-quarter earnings per share [EPS] came in at 14 cents surpassing the Zacks Consensus Estimate of 12 cents and 10 cents reported in the year-ago period. For 2009, the company reported EPS of 53 cents, compared to last year’s 61 cents....   more»

»17/03/2010 [Industry news]
China Leads Pharmerging Countries

IMS Health has upped its count of pharmerging countries to 17 high-growth pharmaceutical markets....   more»

»17/03/2010 [Industry news]
Kendles affiliate gets ISO 9001:2008 certification in China

Kendle, a leading, global full-service clinical research organization, announced its affiliate in China, Beijing KendleWits Medical Consulting Company, has obtained ISO 9001:2008 certification from the International Organization for Standardization, validating the quality and consistency of its operations in this growing region....   more»

China Sky One Medical,Inc. »17/03/2010 [Company watch]
China Sky One Medical, Inc. Announces Fourth Quarter and Fiscal Year 2009 Results

The Companys record revenues in 2009 were primarily driven by positive contribution from the strategic acquisitions that we completed in 2008, heightened consumer brand awareness and expansion of our sales network...   more»

»15/03/2010 [Company watch]
China Medicine Corporation Applies to List on NASDAQ Global Market

China Medicine Corporation, primarily a leading distributor and a developer of Western pharmaceuticals, traditional Chinese medicines (\"TCM\"), and other nutriceuticals, announced today that the the Company has received comments from Nasdaq\'s Listing Qualifications Department in response to its application for listing its common stock on the NASDAQ Global Market. China Medicine submitted the application earlier this year, following the board of directors\' approval of the Company\'s uplisting....   more»

3SBIO (Shenyang Sunshine) »15/03/2010 [Company watch]
3SBio Announces Changes to its Board of Directors

3SBio Inc.(Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced changes to its board of directors (the \"Board\")....   more»

»15/03/2010 [Industry news]
The Week in Review: A Good Week for Life Science Fundings

Industry activities over the last week...   more»

»15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China

Distribution agreement signed between the companies for the marketing of lercanidipine tablets in China...   more»

»12/03/2010 [Other]
Google Denies \'Exit China\' Rumor

Google on Thursday denied it was planning to shut down its business in China by the end of the month, dispelling rumors that it had informed its Chinese advertising agents to cease their business operations in the country....   more»

»11/03/2010 [Company watch]
Chongqing Porton Secures $10 Million for Production Facility

Chongqing DT Fund made its first large-amount investment, for example, pumping US$10M into Chongqing Porton Fine Chemicals Co., Ltd. With this funding, Porton can expand its production scale aggressively....   more»

»11/03/2010 [Company watch]
AutekBio, Suma Ventures & Beijing E-Town to Invest in the Largest CMO Project in Asia

AutekBio, Inc., SUMA Ventures and Beijing E-Town Harvest International Capital Management Corporation, a venture capital group from Beijing Municipal Government announced a joint investment of more than US$100m to develop a new contract manufacturing organization (CMO) for biopharmaceutical industry in China....   more»

»11/03/2010 [Company watch]
Lotus Pharmaceuticals Breaks Ground On New Building

Lotus Pharmaceuticals (OTCBB: LTUS) has begun construction of nine-storey building complex the will provide offices, R&D, production, and storage. The new facility is being built on the grounds of its existing production facility in Beijing. Lotus said that interim production of the drugs to be produced in the new building will continue with contract manufacturers....   more»

»11/03/2010 [Other]
Overseas Investment Regains Confidence in South China

Investment budgets of foreign enterprises in South China increased by 44 percent year-on-year this year, nearly recovering to pre-financial crisis levels, although 3-year budgets lag in recovery. The survey, commissioned by the American Chamber of Commerce in South China and unveiled yesterday, also found its members will reinvest a minimum of $9.4 billion this year, with more than 90 percent considering the business environment to be good, very good or excellent....   more»

»11/03/2010 [Industry news]
China dialysis procedures tightened in wake of hepatitis infections

China is going to tighten supervision over medical practices of hemodialysis, in response to recent cases of hepatitis C infections, the Health Ministry announced....   more»

Sundia MediTech Company,Ltd. »11/03/2010 [Independent reports]
Lady behind Sundia success: Dr Xiaochuan Wang, China

Sundia, a Shanghai-based integrated pharmaceutical contract research organization is the brainchild of a highly motivated Chinese researcher, Dr Xiaochuan Wang, who worked in the US for over 14 years in three biotech companies after her PhD in molecular structure design of new drugs, from the University of Chicago....   more»

Wuxi Pharma Tech »09/03/2010 [Company watch]
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2009 Results

As expected, WuXi PharmaTech (NYSE: WX) reported 2009 net revenues of $270 million, an increase of 7%. Net income climbed to $52.9 million, a great improvement from the loss of $64.2 million in 2008, caused in part by a writedown. In 2009, revenues matched analysts’ expectations, while earnings were slightly below forecasts....   more»

»08/03/2010 [Industry news]
The Week in Review: China Life Science to Grow 22% Per Year Through 2013

Industry activities over the past week...   more»

»08/03/2010 [Other]
China sets 8% target for 2010 economic growth

China expects its economy to grow around 8 percent in 2010 from a year earlier, says a report to be delivered by Premier Wen Jiabao at the annual parliament session Friday. Setting the 8-percent target mainly \"aims at ensuring the quality of economic growth, focusing on transformation of economic development pattern and adjustment of economic structure,\" says the report distributed to media before the opening of the 3rd Session of the 11th National People\'s Congress, the country\'s top legislature....   more»

»08/03/2010 []
Central Government Injects 55.58b Yuan into Social Projects

The total investment injected into social undertakings by the central government since the fourth quarter of 2008 amounted to 55.58 billion yuan ($8.14 billion), supporting approximately 50,000 projects, Li Pumin, spokesman with the National Development and Reform Commission (NDRC), said during an online chat with netizens at on Sunday, xinhuanet reported....   more»

Hutchison China MediTech Limited(“Chi-Med”) »08/03/2010 [Company watch]
Hutchison China MediTech (Chi-Med): Hutchison MediPharma May IPO within Two Years

Chi-Med plans to spin off its drug development arm, Hutchison MediPharma, within two years, possibly through an IPO on the Nasdaq exchange....   more»

»07/03/2010 [Company watch]
Mindray Medical Stays Silent on Reasons for Secondary Offering

Mindray Medical (NYSE: MR), the medical device company, priced a secondary offering of 4 million American depositary shares at $38.20 per ADS, raising $152.8 million in new cash. Mindray closed the previous trading session at $38.00. Because Mindray seems to have plenty of cash, the offering was a surprise, and may indicate the company is eying some future acquisitions....   more»

»05/03/2010 [Other]
SEED Competition for China Life Science Announces Finalists

Roche, OrbiMed, and McKinsey announced fifteen finalists of the SEED Competition at the SEED Finalist Coaching Day event in Shanghai\'s Zhangjiang Hi-Tech Park on March 2, 2010....   more»

Sanofi-Aventis »05/03/2010 [Company watch]
Sanofi-Aventis Looks for More China Partnerships

Sanofi-Aventis (NYSE: SNY) wants to continue building its presence in China. Company officials said Sanofi-Aventis will seek additional partnerships following the joint venture announced last month with Minsheng Pharmaceutical, a JV that will develop vitamin and mineral products in the consumer healthcare sector. Sanofi has gone on record to say it prefers the partnership approach in China, as opposed to building its own R&D center....   more»

Wuxi Pharma Tech
»03/03/2010 [Company watch]
WuXi PharmaTech Forms Pre-Clinical Collaboration With Janssen

WuXi PharmaTech (NYSE: WX) has struck a two-way pre-clinical services deal with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V. WuXi PharmaTech will provide toxicology and other non-clinical services to Janssen, while Janssen will help WuXi attain GLP status in its new Suzhou toxicology lab....   more»

»03/03/2010 [Company watch]
Generex Is Granted a China Patent for Cancer Vaccine 1 comment

Generex Biotechnology (NSDQ: GNBT) announced it has been granted a China patent for its Ii-Key peptide vaccine technology, a vaccine currently in US clinical trials to prevent a recurrence of breast cancer....   more»

»03/03/2010 [Company watch]
Kalen To Offer Lipoprotein Research Products In China

Kalen Biomedical of Maryland, US has found a partner to distribute its lipoprotein research products in China. MingRui Biotech Co., Ltd. of Shanghai, which is already involving in marketing biological reagents, will be Kalen\'s China representative for its portfolio of cardiovascular research tools....   more»

»03/03/2010 [Company watch]
Mindray Medical Reports Stellar 2009 on Strength of China’s Medical Device Market

Mindray Medical (NYSE: MR), the medical device company headquartered in Shenzhen, issued a very positive financial report for 2009. The company recorded revenues of $634 million, an increase of 16%, while net income climbed to $139.2 million, a 28% jump. For 2010, Mindray said it expects revenue growth to continue at a 17% pace; non-GAAP net income is expected to match that rate....   more»

»01/03/2010 [Industry news]
Lightning-Link™ Strikes In China

Innova Biosciences, a Cambridge company is taking its revolutionary antibody labelling kit into China following timely support from UK Trade and Investment (UKTI)....   more»

»01/03/2010 [Industry news]
Biotech- A Week of activity in the Industry

Industry activities over the past week...   more»

»01/03/2010 [Industry news]
China $125 Billion Health Spending Spurs GE, Philips Sales Boon

Wang Huijuan and her husband braved an overnight train ride to Beijing from Anhui province to see a doctor about her ailing intestines. The clinic back home could only take her temperature and blood pressure. The 10,000 yuan ($1,460) in life savings the couple brought to pay their costs may become an expense of the past after the Chinese government spends $125 billion to start a national health insurance system....   more»

»01/03/2010 [Other]
Prudential Plc Agrees to Buy AIA for $35.5 Billion

Prudential Plc, Britain’s biggest insurer, agreed buy American International Group Inc.’s Asian operations for $35.5 billion in cash and stock to gain more than 20 million customers in the region....   more»

Wuxi Pharma Tech
»26/02/2010 [Industry news]
WuXi Pharma COO Highlights Planned Growth

WuXi PharmaTech plans to continue its growth by expanding into biotech, safety evaluation and manufacturing. In fact, to make the growth a reality, the company invests about $60 million each year in capital expenditures....   more»

»26/02/2010 [Industry news]
Asia is an important growth market for Sartorius

Within two decades, Germany-based international laboratory and process technology provider, Sartorius, has built up a strong position in India and Asia by gaining a wider customer base that includes biotech, pharmaceutical and food sectors. Within the entire Sartorius Group, Sartorius India has the second largest workforce with over 500 employees....   more»

»26/02/2010 [Independent reports]
Protecting and Policing IPRs in China

China has emerged as an important economy that enhances registration and enforcement of intellectual property rights (IPRs). China is renowned as the world’s factory, with the emergence of an affluent and growing middle-class....   more»

»25/02/2010 [Industry news]
Merck, Lilly, Pfizer Team Up in Unusual Collaboration for Asian Cancer Database

The database will compile its information using 2,000 tissue samples from patients with lung and gastric cancer. The information will be made available to researchers with the goal of developing new treatments for gastric and lung cancers, which are prevalent in Asia....   more»

»25/02/2010 [Industry news]
CCBC to acquire stake in Shandong Cord Blood Bank

China Cord Blood Corporation, the first and largest cord blood bank operator in China, in terms of geographic coverage, announced that as part of its nationwide expansion strategy, it has entered into an agreement to acquire 19.92 percent equity interest in Shandong Cord Blood Bank (SCBB) for $20.5 million in cash....   more»

»24/02/2010 [Other]
Losing Google would hit Chinese science hard

More than three-quarters of scientists in China use the search engine Google as a primary research tool and say their work would be significantly hampered if they were to lose it, a survey showed on Wednesday....   more»

»24/02/2010 [Industry news]
China Allocates $5.5 billion to Implement Healthcare Reform

China Ministry of Finance (MoF) announced Friday that the central government had authorized the spending of 37 billion RMB ($5.5 billion) as part of its larger 850 billion RMB healthcare reform...   more»

Wuxi Pharma Tech
»23/02/2010 [Industry news]
WuXi toxicology facility gets AAALAC accreditation

Wuxi Pharmatech said that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC)....   more»

»22/02/2010 [Other]
China tuberculosis control project benefits millions

China is second only to India with 4.5 million known TB cases in 2009. WHO estimates there are approximately 1.3 million new cases every year in the country and the disease claimed 160,000 lives in 2008....   more»

China Sky One Medical,Inc. »21/02/2010 [Company watch]
Government Wises Up to China Sky One, Places Ban on Products

Eight products manufactured by China Sky One Medical, Inc. appear in a Chinese government notice of \"counterfeit drug products,\" which states that pharmacies should \"immediately stop the sale\" of these products....   more»

»21/02/2010 [Other]
China to tighten reins on animal feed

Animal feed and feed additive companies are obliged to immediately recall products upon discovery of any defect that may result in harm to animals or people, a draft regulation made public Saturday said....   more»

»20/02/2010 [Industry news]
Novozymes A/S Announces New Production Plant

Novozymes A/S announced that the Company has started building a new plant for production of Bacillus-based hyaluronic acid (BHA)....   more»

»20/02/2010 [Industry news]
Shanghai RAAS Blood Products Co., Ltd. to Set up Beijing Branch

Shanghai RAAS Blood Products Co., Ltd. announced that it will establish a Beijing Branch....   more»

»20/02/2010 [Industry news]
Private healthcare regulations to be loosened to spur investment, doubts remain

The Ministry of Health (MOH), National Development and Reform Commission (NDRC), Ministry of Commerce (MOFCOM), and other agencies plan to draft a document to encourage private investment in service industries, including healthcare delivery in the form of private hospitals....   more»

»19/02/2010 [Industry news]
BioNeutral Group To Form New Wholly Owned Subsidiary In Hong Kong

BioNeutral Group, Inc. announced that it will form a new wholly owned subsidiary in Hong Kong to commercialize its chemical formulations throughout Asia....   more»

»18/02/2010 [Industry news]
Bio-Bridge Science Builds New GMP Research And Manufacturing Facility In China

M2 EquityBites reported that Bio-Bridge Science, Inc. has completed the construction of a new GMP research and manufacturing facility in Beijing, China....   more»

Bayer »18/02/2010 [Company watch]
Bayer Seeks Better Than 20% Growth in China

China’s dissemination of health care insurance throughout the country will power 20% annual growth in spending for medicines in the country, according to Liam Condon, who spearheaded Bayer AG’s (BAYRY.PK) operations in China until the end of 2009. Bayer [XETRA: BAY] itself expects to produce returns that beat the 20% rate of growth....   more»

»18/02/2010 [Industry news]
Narhex Declares Bankruptcy; Involved in Xi’an JV

Narhex Life Sciences, an Australian pharma whose main asset was a China joint venture, has declared bankruptcy....   more»

»17/02/2010 [Industry news]
Tracking China BioPharma in the past 10 days

A Review of Activities in the China Bio Pharm industry...   more»

»17/02/2010 [Industry news]
CRH Medical Announces International Expansion to China

CRH Medical Corporation announced today that it has signed a product distribution agreement with Rayfield Technologies to sell the Company\'s proprietary hemorrhoid technology, the CRH O\'Regan System(TM), in China....   more»

Charles River
»16/02/2010 [Company watch]
Charles River Labs Disappointed by Weak Demand for China Lab

Charles River Labs declared itself surprised at the low level of demand for its China CRO services. The company opened its lab in October 2008 and, almost immediately after, it was said to be looking for a second site....   more»

»16/02/2010 [Industry news]
Quintiles, Inc. Launches New Tissue Testing Services in China

Quintiles today announced the availability of anatomic pathology services through its central laboratory in Beijing, China, to help biopharmaceutical companies develop more effective cancer treatments....   more»

»16/02/2010 [Company watch]
Thermo Fisher Scientific building a second demo lab in China.

Thermo Fisher Scientific , a maker of lab equipment, said it is building a second demo lab in China. This one will be in Beijing, home to many of the country’s leading universities and research institutions. Thermo’s first facility is in Shanghai, which Thermo characterizes the site of a wide array of global pharmaceutical companies....   more»

»16/02/2010 [Industry news]
Skystar Bio-Pharmaceutical (CGPN) Included in New York Pacific Capital China SME Growth Index

Skystar Bio-Pharmaceutical Company, a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced the Company\'s inclusion in the New York Pacific Capital (NYPC) China Small and Medium Enterprises (SME) Growth Index....   more»

»15/02/2010 [Company watch]
Parexel International experienced a strong growth in demand

Meanwhile, another Boston area company, Parexel International a clinical stage CRO, has experienced a strong growth in demand for its services in China. The company has upped its headcount to 1,600 from 1,000 just two years ago, its business coming from multinational big pharmas....   more»

»11/02/2010 [Industry news]
Medical International achieves milestone in China

Medical International Technology, which specializes in the development, production, marketing and sale of needle-free injectors announced that its Chinese joint venture has achieved a major milestone and received the production certification to produce Med-Jet products in China....   more»

3SBIO (Shenyang Sunshine)
»11/02/2010 [Company watch]
3SBio and Panacor Bioscience Enter Collaboration and License Agreement

3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil® for Hyperphosphatemia...   more»

Simcere Pharmaceutical Group »11/02/2010 [Company watch]
Simcere Pharmaceutical Group Receives FDA Approval to Manufacture and Sell Zanamivir in China

Simcere Pharmaceutical Group , a leading pharmaceutical company specialising in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that one of its subsidiaries, Nanjing Simcere Dongyuan Pharmaceutical Co. Ltd., has received new drug registration approval from the State Food and Drug Administration to manufacture and sell Zanamivir, a neuraminidase inhibitor inhalant...   more»

Roche »11/02/2010 [Industry news]
CapitalBio Corporation Certified to Provide Roche NimbleGen, Inc Array Services in China

Roche NimbleGen announced today that Beijing-based genomic services provider CapitalBio has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program....   more»

»10/02/2010 [Industry news]
Broad RNAi Patent Granted To Allele Biotechnology In China

Allele Biotechnology & Pharmaceuticals, a San Diego based private company with associate offices and laboratories in China and distribution channels in 30 countries, was granted a major landmark patent in China in the field of RNA interference (RNAi)....   more»

»10/02/2010 [Other]
China GDP to grow 9.5% in 2010

China has little chance of incurring severe inflation in 2010 and CPI will grow about three percent year-on-year, China Securities Journal reported Wednesday, citing a report from China Construction Bank....   more»

»10/02/2010 [Finance]
China May Choose Wages Over Yuan Gains to Cut Surplus

China, under international pressure to reduce its trade surplus, may choose to shrink it through raising workers’ wages rather than letting the yuan appreciate, Credit Suisse Group AG said....   more»

»10/02/2010 [Industry news]
SFDA Med Equipment Supervision and Management Meeting drafts goals for 2010

Jingli Zhang, deputy director of the State Food and Drug Administration (SFDA), highlighted five main areas of focus for 2010....   more»

»09/02/2010 [Other]
Remember your liver - China warns in advance of China New Year

China is getting ready for the Spring Festival bash, and that means lots of drinking, day after day, night after night, toast after toast. Not to drink is considered very impolite....   more»

»09/02/2010 [Industry news]
India Big pharma slashes R&D budget: A reason of concern?

Indian pharma companies have announced a major reduction in their R&D budgets in the coming years. What repercussions will it create on the pharma industry? Within a span of eight days, the pharma industry has seen three top notch companies cutting down on their R&D investments and downsizing its scientific workforce. Increasing R&D productivity was the unanimous reason given out by the heads of these companies....   more»

»09/02/2010 [Company watch]
Tianyin Pharma Q2 2010 revenue up 47%

Tianyin Pharmaceutical, a manufacturer and supplier of modernized traditional Chinese medicine based in Chengdu, China, announced that its revenue for the second quarter of fiscal 2010 was approximately $14.9 million, an increase of 47.9 percent compared to $10.1 million for the second quarter of fiscal 2009....   more»

»09/02/2010 [Company watch]
Chindex reports 12% increase in Q3 revenue

Chindex International, an American provider of Western healthcare products and services in China, announced that its revenue in the third quarter of fiscal year 2010 increased 12 percent year over year to $46.5 million. The net income for the third quarter of fiscal 2010 too increased to $3.9 million, from $846,000 in the prior year period....   more»

»08/02/2010 [Industry news]
ChemPartner gets best partner award from Roche China

Shanghai ChemPartner, a China-based contract research organization and a wholly owned subsidiary of ShangPharma, announced that it has received the 2009 Most Valuable Partner (MVP) Award from Roche R&D Center China (RRDCC) for excellent service and outstanding contributions in the area of oncology and diabetes pharmacology research...   more»

»08/02/2010 [Industry news]
China to implement Reform Plan

China will implement its reform plan for public hospitals by establishing pilot programs that move away from the profit motive,...   more»

»08/02/2010 [Industry news]
Highlighting a week of Activities in China Pharma

China compiles inclusive list on medicine use to guide doctors Shanghai Pharmaceutical Group digests recent acquisitions but still hungry for more, will keep name Chinese experts: No evidence yet to show GM food unsafe NeoStem Eyre Subsidiary Approved to Use New Manufacturing Facility Tongjitang Chinese Medicines Pays High for Liquor Therapy China Biologic appoints independent director Sanofi, Minsheng in consumer healthcare deal Huifeng Bio-Pharma anticipates 30% revenue growth for 2009 China Sky One Medical, Inc. Receives Benefits Following Relocation of Corporate Headquarters Burdica to Enter China with Landmark Deal With Sinopharm Group China threatens world health by unleashing waves of superbugs China to Implement Reform Plan Zhejiang Hisun Pharmaceutical Co partners Sagent Pharm...   more»

»08/02/2010 []
Next Week: New Publication Day

Due to China New Year Activities, please kindly note that next week newsletter will be published on Wednesday 17th February...   more»

»08/02/2010 [Industry news]
There will be blood... Shenzhen Guangming plans new plasma product facility

Shenzhen Weiwu Guangming Biological Products announced February 3 that it will invest RMB 170 million to build the largest blood-products production base in southern China according to,   more»

»08/02/2010 [Industry news]

Gorbec Pharmaceutical Services, a rapidly expanding contract developer and manufacturer of prescription pharmaceutical products, is opening a GMP-compliant analytical laboratory in Yantai, China....   more»

»07/02/2010 [Other]
China compiles inclusive list on medicine use to guide doctors

The China Ministry of Health (MOH) on Sunday released an inclusive list of illustrations on medicine use as guidance for doctors in writing prescriptions. It is the first state-level list of its kind in the country....   more»

»06/02/2010 [Other]
Chinese experts: No evidence yet to show GM food unsafe

Chinese food and agricultural experts said no evidence has proved genetically-modified crops are unsafe for people and the environment....   more»

»05/02/2010 [Industry news]
China threatens world health by unleashing waves of superbugs

China\'s reckless use of antibiotics in the health system and agricultural production is unleashing an explosion of drug resistant superbugs that endanger global health, according to leading scientists....   more»

»05/02/2010 [Industry news]
Huifeng Bio-Pharma anticipates 30% revenue growth for 2009

Huifeng Bio- Pharmaceutical Technology, a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, announced preliminary 2009 results and provided guidance for 2010....   more»

»05/02/2010 [Industry news]
China Biologic appoints independent director

China Biologic Products, a leading plasma-based biopharmaceutical company in China, announced that, effective February 4, 2010, the company has appointed Dr. Xiangmin Cui, to serve as an independent member of its board of directors, as the Chairman of the company\'s Compensation Committee, and as a member on the company\'s Audit Committee and Nominating Committee....   more»

»05/02/2010 [Industry news]
Morningside and Can Fite BioPharma to Establish a Joint Venture

Morningside and Can Fite BioPharma to Establish a Joint Venture to Develop and Commercialize Can-Fite\'s CF-102 Drug for the Treatment of Liver Diseases...   more»

»04/02/2010 [Industry news]
Burdica to Enter China with Landmark Deal With Sinopharm Group

Scottish biotech company Burdica Biomed – an alumnus of EPIS (the Edinburgh Pre-Incubator Scheme) – has sealed an eight-figure distribution deal for several of its products with Sinopharm, China’s largest pharmaceutical and medical device distributor....   more»

»04/02/2010 [Industry news]
Tongjitang Chinese Medicines Pays High for Liquor Therapy

Tongjitang Chinese Medicines Company (NYSE: TCM), a company focused on modernized TCM products, has set up a joint venture to acquire Guiyang Liquor Factory, a state-owned company, for 120.6 million RMB ($17.7 million) in cash. Tongjitang, which owns 95% of the joint venture, will pay its share of the consideration in full by February 2010....   more»

»04/02/2010 [Industry news]
Zhejiang Hisun Pharmaceutical Co partners Sagent Pharm

Zhejiang Hisun will presumably join Sagent’s global network, which includes 20 partners, over 60 facilities and access to 1,400 R&D employees worldwide....   more»

»02/02/2010 [Other]
China dispatches food safety inspectors after melamine-contaminated milk resurfaces

(Xinhua) -- China has dispatched inspectors to 16 provinces to urge local authorities to thoroughly investigate cases concerning food safety, the government\'s latest move against a string of reportedly resurfacing melamine-tainted milk products after a nationwide crackdown in 2008....   more»

»02/02/2010 [Industry news]
NeoStem: Eyre Subsidiary Approved to Use New Manufacturing Facility

NeoStem reported its China subsidiary, Suzhou Erye Pharma, was approved by the SFDA to begin manufacturing two penicillin products at the company’s new facility....   more»

»02/02/2010 [Industry news]
SPG digests recent acquisitions but still hungry for more, will keep name

Shanghai Pharmaceutical Group (SPG), which is planning for six months of company integration efforts after its recent acquisitions, will retain the same company name going forward....   more»

»01/02/2010 [Industry news]
Shanghai Jiao Tong University makes male infertility gene discovery

Shanghai Jiao Tong University\'s School of Medicine has identified one gene involved with sperm development that could lead to new male infertility treatments and new approaches to male contraception....   more»

»01/02/2010 [Industry news]
China Biotech in Review: to 1st Feb 10

A week of China Biotech activity...   more»

»01/02/2010 [Other]
China Sustains Expansion as Inflation Pressures Grow

China, the world’s third-biggest economy, sustained its manufacturing expansion in January as export orders jumped and inflation pressures grew, two surveys showed today....   more»

Sanofi-Aventis »01/02/2010 [Industry news]
Sanofi, Minsheng in consumer healthcare deal

French drug giant Sanofi-aventis has signed an agreement with Minsheng Pharmaceutical of China to form a new consumer healthcare joint venture....   more»

»01/02/2010 [Industry news]
Achillion Announces License Agreement for Elvucitabine Development in China

(GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. today announced the execution of a license agreement for elvucitabine, the Company’s nucleoside reverse transcriptase inhibitor (NRTI) for the treatment of both hepatitis B virus (HBV) infection and human immunodeficiency virus (HIV) infection with GCA Therapeutics, Ltd. (GCAT) of Jersey City, New Jersey....   more»

China Sky One Medical,Inc. »01/02/2010 [Company watch]
China Sky One Medical, Inc. Receives Benefits Following Relocation of Corporate Headquarters

China Sky One Medical , a leading fully integrated pharmaceutical company producing over-the-counter drugs in China, today announced the receipt of government supported policies following the recent move of its corporate headquarters to Songbei New District, Harbin City....   more»

»31/01/2010 [Company watch]
Covance Increases Emerging Markets Focus: Building Pre-Clinical Facility in China

Joe Herring, Chairman and CEO of Covance, estimated the company will make an investment of between $20 to $25 million to establish the pre-clinical facility, part of which was spent in 2009....   more»

»31/01/2010 [Industry news]
Glaxo Smith Kline set to slash 4,000 jobs

Pharmaceutical giant pushes into emerging markets as it squeezes costs in the West...   more»

»29/01/2010 [Industry news]
Beijing city prolongs suspense, will name 10 winning distributors after CNY

The ten distributors authorized to carry out centralized drug distribution in Beijing region will be announced after the Chinese New Year,...   more»

»29/01/2010 [Company watch]
Sinovac announces pricing of common share offering

Sinovac Biotech, a leading China-based vaccine manufacturer, announced that it has priced its public offering of 10,000,000 common shares at $5.75 per common share....   more»

Novo Nordisk »29/01/2010 [Company watch]
Novo Nordisk Awaits China Approval of Type 2 Diabetes Treatment

Novo Nordisk reported that Victoza®, its once-daily human glucagon-like peptide-1 (GLP-1) analog for type 2 diabetes, was submitted to the SFDA in August of last year....   more»

»28/01/2010 [Other]
China reports smaller proportion of A/H1N1 in all flu cases

(Xinhua) -- A/H1N1 flu cases in the Chinese mainland last week took up 26.8 percent of all flu cases, down from 39.1 percent the previous week....   more»

Bayer »28/01/2010 [Industry news]
Chasing Exforge- Bayer Schering starts CCB/ARB antihypertensive trial in China

Bayer Schering announced January 26 that it has begun phase IV clinical trials of a new antihypertensive combination in the Asia Pacific region in which China will play an essential role,...   more»

»28/01/2010 [Industry news]
Chinese firm to develop biopharma incubator

Chinese enterprise Changzhou Fangyuan Pharmaceutical is planning to develop a bio-pharmaceutical incubator at the Changzhou National High-Tech District, Jiangsu province in China....   more»

»28/01/2010 [Industry news]
Varian Medical Systems (VAR) Receives Certification to Assemble X-Ray Tubes in China

ian Medical Systems, Inc. , a premier supplier of X-ray tubes and flat panel digital image detectors, today announced it has been given certification to assemble and service X-ray tubes in China to support its growing customer base of X-ray equipment manufacturers and service organisations....   more»

»27/01/2010 [Industry news]
Shandong permits government insurance reimbursement at private hospitals

Shandong Province recently issued the `Opinion on the Development of Private Medical Institutions, which explicitly states that private medical institutions will be subject to the same policies as public hospitals....   more»

»25/01/2010 [Industry news]

...   more»

»25/01/2010 [Industry news]
News Items over the past week in China

Company activities in the China bio industry...   more»

»25/01/2010 [Finance]
China May Consider One-Time Yuan Gain, Goldman Sachs O’Neill Says

China will probably let its currency appreciate by at least 5 percent in a one-time move and raise interest rates to cool the economy and curb inflationary pressures, Goldman Sachs Group Inc. Chief Economist Jim O’Neill said....   more»

»25/01/2010 [Industry news]
CanFite/Morningside JV to develop novel liver therapeutic in Greater China

CanFite and Morningside will setup a joint venture (JV) company, which will receive exclusive rights to intellectual property related to CanFite\'s novel liver disease treatment...   more»

»24/01/2010 [Other]
China to close thousands of liaison offices in Beijing

China plans to close thousands of offices established by regional governments in Beijing following longstanding allegations of corruption, the influential Outlook Weekly reported in its latest issue....   more»

»22/01/2010 [Industry news]
China-Biotics, Inc. Appoints New Chief Financial Officer

China-Biotics, Inc. a leading Chinese firm specialising in the manufacture, research, development, marketing and distribution of probiotics products, today announced the appointment of Mr. Travis Cai as Chief Financial Officer, effective January 22, 2010....   more»

»22/01/2010 [Industry news]
Sinovac plans to sell 8.6 mn common shares

Chinese vaccine major, Sinovac Biotech is planning to sell 8.65 million common shares of the company in an underwritten public offering. Sinovac plans to grant the underwriters an option to purchase up to an additional 1.29 million common shares to cover over allotments....   more»

»22/01/2010 [Company watch]
Pfizer Sees Future Deals as China Biopharma Consolidates

To increase dealmaking in China, Pfizer has built a Shanghai-based business development team. On the one hand, the mega-pharma is looking forward to revenue growth in the China pharma market, while on the other hand it expects China’s famously fragmented pharmaceutical industry to begin a long-awaiting process of consolidation....   more»

China Sky One Medical,Inc.
»21/01/2010 [Company watch]
China Sky One Medical, Inc. Announces Tianlong Subsidiary to Focus R&D Efforts on Antibiotics and Cardiac Drugs

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in China, today announced that Heilongjiang Tianlong Pharmaceutical Company , the Company\'s wholly owned subsidiary, will change its R&D focus from external use medicines to antibiotics and cardiac drugs....   more»

China Aoxing Pharmaceutical Company, Inc. »20/01/2010 [Industry news]
China Aoxing Pharmaceutical Corp. Announces Appointment of New Chief Financial Officer

China Aoxing Pharmaceutical Company, Inc., a pharmaceutical company specialising in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that it has appointed Dr. Hui Shao as Chief Financial Officer, effective immediately....   more»

»20/01/2010 [Industry news]
CEO of NeoStem, Inc. Says China Will Play a Key Role in Company Future

\"We think therapy is what is going to drive our business model; our company has grown over the last two and a half years from a single line to being a real therapeutics company,\" says Smith....   more»

»20/01/2010 [Independent reports]
All Eyes on Chinese healthcare market

The overall compound annual growth rate of the pharmaceutical market (2009-2013), for its part, is projected to be 24%, with the market reaching an estimated $73 billion by 2013 (at constant exchange rates)....   more»

China Sky One Medical,Inc. »19/01/2010 [Industry news]
China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters

the Company has relocated its headquarters to its new buildings in the Harbin Song Bei New Development district...   more»

»18/01/2010 [Industry news]
A Week in Review: to January 18

A week of activity in the China Biotech Industry...   more»

»18/01/2010 [Other]
China Inflation May Quicken, Hurting Banks, Utilities

China’s inflation rate may accelerate to as high as 8 percent this year, hurting banking, utility and phone stocks, according to BNP Paribas....   more»

»18/01/2010 [Industry news]
Accellerator Company formed to assist US Life Science companies

At its ChinaBio® Executive Workshop held during the JPMorgan conference here, ChinaBio® LLC, a U.S. company based in San Diego and Shanghai, announced that it has formed a China domestic company to help U.S. life science companies establish operations and enter the China market more quickly and safely than they could on their own. This concept has been used successfully in the web industry by Baidu, Google’s primary competitor in China, but ChinaBio believes this is the first time that it has been applied to the life science industry....   more»

»17/01/2010 [Industry news]
China reports 630,000 cases of adverse drug reactions in 2009

(Xinhua) -- China\'s adverse drug reaction (ADR) monitoring center received more than 630,000 reports of such cases in 2009, according to the State Food and Drug Administration...   more»

»16/01/2010 [Other]
Scientists discover avian influenza outbreak closely related to bird migration

A research jointly conducted by Chinese and Asian scientists has discovered that highly pathogenic avian influenza (H5N1) outbreak was closely related to bird migration....   more»

»11/01/2010 [Industry news]
Beike Biotech, Jiangsu University, Nanjing Hospital receive $1.8 mn for hUC-MSC R&D

The Jiangsu Government\'s Science and Technology Department has announced a $1.8 million grant - the Jiangsu Technological Achievements Transformational Grant - to support the research and development of human umbilical cord mesenchymal stem cell (hUC-MSC) technologies. The grant recipient and administrator, Shenzhen Beike Biotechnology Co., Ltd., is working with Jiangsu University and Nanjing University\'s Drum Tower Hospital to fulfill the grant\'s requirements....   more»

Wuxi Pharma Tech
»11/01/2010 [Company watch]
Qiagen, WuXi AppTec work together for biomarker development

Qiagen Asia Pacific and WuXi AppTec announced a partnership to provide an integrated single solution for molecular biomarker development, validation and personalized healthcare targets to their respective client bases, with Qiagen providing a complete portfolio of instrumentation, training, and consumables and WuXi AppTec providing laboratory facilities and staff to execute the services....   more»

»11/01/2010 [Other]
Public Hospital Reform Plan Delayed

...   more»

»11/01/2010 [Other]
Watchdog Moves to Tighten Scrutiny on Drug Market

China\'s State Food and Drug Administration (SFDA) has ordered local drug watchdogs to tighten market surveillance as it exposed eight unregistered websites marketing and selling medicines that could allegedly treat diseases such as high blood pressure. The websites, including the Beijing-based, had been engaged in illegal dealing of medicines in the name of non-existent organizations or legal drug manufacturers, said a statement on the SFDA website. The websites were still accessible....   more»

Bridge (Vital Bridge)
»11/01/2010 [Industry news]
Pharmaron LLC Expands Portfolio of Services with Acquisition of Bridge Laboratories China

Pharmaron Holdings Limited, today announced it completed the acquisition of Bridge Laboratories China....   more»

»10/01/2010 [Other]
Average salary of SOE execs around 600,000 yuan in \'09: official

The average annual pay for senior executives of State-owned enterprises (SOEs) last year hit around 600,000 yuan (US$87,840), which is not too high, said an official from the State-owned Assets Supervision and Administration Commission (SASAC),...   more»

»10/01/2010 [Industry news]
China Biotech Week to Jan 10

ChinaBio Today: Life science in China kicked off the new year with announcements of new investments, indicating the financial pressure for growth has carried over into 2010. There was also news on other fronts, as companies continued to develop their product portfolios....   more»

»09/01/2010 [Industry news]
China Yongxin projects 22% drop in revenue in 2009

China Yongxin Pharmaceuticals, a leading manufacturer, distributor and retailer of Chinese traditional medicines, pharmaceutical products, natural health products, health food, cosmetics, and medical equipment in Northeastern China, announced its projected financial results for the year ending December 31, 2009....   more»

»08/01/2010 []
China drug watchdog orders tightened market supervision

China State Food and Drug Administration (SFDA) has ordered local drug watchdogs to tighten market surveillance as it exposed eight unregistered websites marketing and selling medicines that could allegedly treat diseases such as high blood pressure....   more»

»08/01/2010 [Independent reports]
China\'s Vaccine Sector: How to Get in the Game

China vaccine sector will grow 25 percent annually, according to a report from Zero2IPO, a Chinese venture-capital firm. In 2012, the size of the market will reach \"8 billion yuan\", the report said....   more»

»08/01/2010 [Company watch]
3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM)

3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has submitted its application for a registrational clinical trial to the Chinese...   more»

»08/01/2010 [Company watch]
China Medicine Corporation Enters Into a $69.6 Million Financing Agreement with One Equity Partners

China Medicine Corporation (OTC Bulletin Board: CHME) (\"China Medicine\" or \"the Company\"), primarily a leading distributor and a developer of Western pharmaceuticals, traditional Chinese medicines (\"TCM\"), and other nutriceuticals today announced that it has entered into a Stock Subscription Agreement for an equity private placement (the \"Subscription Agreement\") with One Equity Partners (\"OEP\"), the global private equity investment arm of JPMorgan Chase & Co....   more»

Shanghai ChemPartner Co.,Ltd. »07/01/2010 [Company watch]
Shanghai ChemPartner Places Third in Fast 50 China

Shanghai ChemPartner, as the flagship subsidiary of ShangPharma, a leading China-based Contract Research Organization (CRO), today announced it is a winner of the 2009 Deloitte Technology Fast 50 China, ranking 3rd on the list of the fastest-growing high tech companies in China. The award is a testament to ChemPartner\'s outstanding three-year revenue growth from 2006 to 2008....   more»

»06/01/2010 [Other]
Vaccine Makers Bet on Healthcare Plan

The domestic vaccine production market is expected to expand quickly in the years ahead as investors look to capitalize on the nation\'s healthcare reforms and enhanced public awareness about inoculations....   more»

China Sky One Medical,Inc. »05/01/2010 [Company watch]
China Sky One Medical, Inc. Announces Move to NASDAQ Global Select Market

China Sky One Medical, Inc. a leading fully integrated pharmaceutical company developing and producing over-the- counter drugs in China, today announced that the Company\'s securities will be listed on NASDAQ Global Select Market effective January 4, 2010....   more»

»04/01/2010 [Industry news]
Economic Growth Set to Continue into New Year

The country\'s economic growth looks set to accelerate into the new year, with booming factory production driving figures of a December manufacturing survey to a 20-month high....   more»

»02/01/2010 [Industry news]
The Week in Review: Year-End IPO Review

A week of activities in China bio industry....   more»

»02/01/2010 [Other]
Wen: Science, Technology Key to China\'s Economy

Premier Wen Jiabao said on Sunday that China would rely on science and technology to change its growth pattern....   more»

»31/12/2009 [Industry news]
China-listed Life Science IPOs Are Hot

In a maker of TCM products including the Watermelon Frost line. The IPO price was set at 19.8 RMB, the size of the offering was increased, and the shares rose in open market trading. At the end of the year, Guilan Sanjin closed at a price of 27.91 RMB, an increase of 41% for the IPO investors....   more»

»30/12/2009 [Company watch]
Syngenta Biotechnology Breaks Ground on Beijing R&D Center

Syngenta Biotechnology, a division of the Swiss giant agribusiness company Syngenta (NYSE: SYT), has begun construction of an R&D center in Beijing. When the company announced its intention to build the center, it committed $100 million to developing the project over the next five years. The China facility will concentrate on evaluating genetic modifications for key crops such as corn and soybeans, with the goal of improving yields, drought resistance, disease control and biomass conversion for biofuels....   more»

»30/12/2009 [Industry news]
The Week in Review: Holiday Transactions and Awards

A week of industry activities....   more»

»30/12/2009 [Industry news]
Mixed Results For China Life Science US IPOs

In the last two months, three China life science companies have made their debuts on US exchanges. The most important insight from these IPOs is that they actually took place. In the previous 12 months, the worldwide economic crisis prevented almost all IPO activity, so a completed IPO became reason enough to celebrate....   more»

»29/12/2009 [Company watch]
Sinovac Files to Begin Vaccine Trial for Hand, Food and Mouth Disease

Sinovac Biotech (NSDQ: SVA) has applied to the SFDA to begin a clinical trial for a vaccine that protects against human enterovirus 71 (EV 71), which causes hand, foot, and mouth disease (HFMD). Sinovac began work on the vaccine over one year ago with research help from the CDC of China. At that time, Sinovac said enterovirus infections did not have specific treatments or a preventative vaccine. The company’s clinical trial application for a HFMD vaccine is the first filed in China....   more»

»29/12/2009 [Company watch]
Biostar Pharma To Launch Xin Aoxing Oleanolic Acid Capsules In Beijing And Shanghai

Biostar Pharmaceuticals Inc. completed preparation to launch its flagship Xin Aoxing Oleanolic Acid Capsules for the treatment of Hepatitis B in Beijing and Shanghai in early January 2010. Management anticipates approximately $9 million in incremental revenues during 2010 from these two new markets with average gross margins of approximately 72%....   more»

»29/12/2009 [Company watch]
Ranbaxy Sells China Manufacturing JV

Ranbaxy Laboratories has sold its share in a China manufacturing JV, Ranbaxy Guangzhou China (RGCL), to HNG Chembio Pharmacy Co Ltd. Terms were not disclosed. The sale was thought to have been spurred by Ranbaxy\'s desire to rationalize its worldwide operations after Japan\'s Daiichi Sankyo purchased a 64% stake in Ranbaxy in June 2008. Ranbaxy will continue to supply the China market with pharmaceutical products, though from a different facility....   more»

»28/12/2009 [Industry news]
TCM Treatment Announced for H1N1 Flu

Chinese medical specialists announced Thursday they had developed a Chinese herbal medication to treat the A/H1N1 flu....   more»

»23/12/2009 [Company watch]
Hard to Treat Diseases to sell MindUp BioResearch division to Chinese herbal company

Hard to Treat Diseases, Inc. (HTDS), a US-based provider of immunostimulant for combating cancer and rheumatoid arthritis under medical patent, has agreed to sell its Serbia-based MindUp BioResearch division to a herbal medicine company in China....   more»

Wuxi Pharma Tech »22/12/2009 [Company watch]
WuXi and Sundia Named Again to Deloitte\'s Fast 500 Asia Pacific

Two of China’s major CROs were named to Deloitte Technology Fast 500 Asia Pacific list, an award that recognizes the fastest growing technology companies in the Asia Pacific region. It was WuXi PharmaTech’s (NYSE: WX) sixth appearance on the list, a remarkable achievement given that the company was formed in December 2000. For Sundia MediTech, an even younger company, it was the second year in a row to be included in Fast 500....   more»

»22/12/2009 [Company watch]
Alvogen Opens Office in China

Alvogen announced December 15 that the company has commenced Asia operations with the establishment of a corporate presence in Shanghai, the Medical News reported. The new subsidiary in China will source active pharmaceutical ingredients and finished products for the company\'s business units in North America, Europe and Asia, and will also serve as a springboard for business development efforts in the China and Asia markets....   more»

»22/12/2009 [Company watch]
Astellas Wins Approval for Overactive Bladder Treatment in China

Astellas Pharma (ALPMF.PK) of Japan said it received SFDA approval for Vesicare, a treatment for Overactive Bladder (OAB). The drug, an antispasmodic, relaxes the muscle in the bladder, reducing leaking of urine and the powerful urge to urinate before the bladder is filled. Astellas China will begin marketing Vesicare immediately....   more»

Hutchison China MediTech Limited(“Chi-Med”) »22/12/2009 [Company watch]
Hutchison Chi-Med to Outsource Development of a TCM

Hutchison Chi-Med, the Chinese medicine company backed by the firm that created mobile phone group Orange, has signed up the University of Cambridge to investigate the potential healing and anti-aging properties of a number of the group\'s herbal remedies....   more»

»22/12/2009 [Company watch]
Sinovac Named Among China\'s Top 10 Most Competitive Companies

Sinovac Biotech Ltd. (NSDQ: SVA) was selected by China Business Media as one of China\'s Top 10 most competitive companies listed overseas for 2009. The honor was given to Sinovac at the 2009 China Business Annual Meeting on Enterprise Competitiveness....   more»

»21/12/2009 [Other]

With warmest wishes for an enjoyable Christmas and a Healthy, Happy and Prosperous 2010. From everyone at ACIL Shasha, Michael, Youcheng & Kevin...   more»

»21/12/2009 [Company watch]
Covance Expands Offices in Japan and Hong Kong

Covance Inc. today announced the opening of new clinical development offices in Seoul, South Korea and Mumbai, India and office expansions in Tokyo, Japan and Hong Kong, China to accommodate growing demand for clinical development services in Asia-Pacific....   more»

»21/12/2009 [Finance]
China Is Targeting 8% Economic Growth Next Year

China, the world’s third-biggest economy, is targeting 8 percent growth in 2010 amid a “fragile” global recovery, industry minister Li Yizhong said....   more»

»21/12/2009 [Industry news]
Seahorse Bioscience appoints Cell-Bio as distributor in Taiwan

Seahorse Bioscience, the leader in the design and development of instruments for assessing cellular bioenergetics, announced Cell-Bio Biotechnology as the distributor of Seahorse XF Analyzers and consumables in Taiwan at the 6th Conference of the Asian Society for Mitochondrial Research and Medicine in Taipei....   more»

»20/12/2009 [Industry news]
A Review of China Biotech Activities

A week of activities in the China Biotech sector...   more»

»20/12/2009 [Company watch]
Pfizer Extends Relationship with Peking University for Drug Discovery

Pfizer will provide funds to support projects “of mutual interest,” and it will help support a translational research and drug discovery centre that PKU intends to build....   more»

»18/12/2009 [Industry news]
Alvogen launches Asia operations

Alvogen China will also serve as a global sourcing unit for active pharmaceutical ingredients and finished products that will be used throughout the company’s regional business units that encompass North America, Europe and Asia....   more»

»18/12/2009 [Industry news]
American Oriental Bioengineering, Announces the Inclusion of 158 Drugs in China\'s National Insurance Catalog

The company today announced that 158 of the Company\'s drugs have been included in China\'s National (Medical) Insurance Catalog (the \"2009 NIC\"). Of these, 82 are categorized as Class A drugs and 76 are categorized as Class B drugs. Most importantly, Jinji Capsule, AOBO\'s best selling national branded product, has been added to the 2009 NIC since its last publication in 2004....   more»

»17/12/2009 [Other]
Foreign money to China surges

China\'s foreign direct investment (FDI) reached its highest total in 16 months during November, sustaining the rising trend since August,...   more»

»17/12/2009 [Other]
China succeeds in developing herbal medication to treat A/H1N1 flu

Chinese medical specialists announced Thursday they had developed a Chinese herbal medication to treat the A/H1N1 flu....   more»

Roche »17/12/2009 [Industry news]
Roche lends helping hand to MOH to support organ transplant programs

Roche Pharmaceuticals is teaming up with the Ministry of Health (MOH) to launch the China Organ Transplant Development Program, according to Beijing Youth Daily December 16....   more»

»17/12/2009 [Finance]
CCBI medical fund reaches capital target, ready to invest

China Construction Bank International (Holdings) Ltd. (CCBI) announced December 16 that it has raised RMB 3 billion in capital for its new medical investment fund....   more»

»17/12/2009 [Industry news]
History of China Medstar Sheds Light on Concord Medical Services

Concord Medical Services (CCM), a leading Chinese operator of radiotherapy and diagnostic imaging centers in China, went IPO last Friday at a price of $11. The stock closed the first day of trading at $9.5, down 13.6%....   more»

Novartis »16/12/2009 [Company watch]
Novartis Increases China Commitment: Opens Suzhou Plant, Technical R&D Centre

In November, Novartis held the official opening of Suzhou Novartis Pharma Technology Co., the company’s new $250 million centre devoted to technical R&D as well as manufacturing of APIs and intermediates....   more»

»16/12/2009 [Industry news]
CCTV nominates Sinovac CEO for Economic Man-of-the-Year Award

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that Mr Weidong Yin, Chairman, President & CEO, was selected by China Central Television (CCTV) to be one of 18 nominees for the China 2009 Economic Man-of-the-Year....   more»

»14/12/2009 [Industry news]
A Week of News

Industry activity in the last seven days...   more»

Merck & Co »14/12/2009 [Company watch]
Merck Starts China Trial of Cancer Vaccine

Merck KGaA (MRK) of Germany will conduct a multi-national Phase III clinical trial of the therapeutic cancer vaccine Stimuvax in Asian patients....   more»

Eli Lilly & Co
»14/12/2009 [Company watch]
Lilly Aims at the Growing China Pharmaceutical Market

In an annual review of its business plans, Eli Lilly (LLY) revealed China’s pharmaceutical market will be a top priority for the company....   more»

»14/12/2009 [Independent reports]
Primary healthcare sector in China surges ahead

Primary healthcare facilities concept, better known as Community Health Centers (CHC) and Community Health Stations (CHS) in urban China, was first initiated in 1997, to address the rising public cries towards increasingly unaffordable and inaccessible healthcare at the tertiary care hospitals in the urban cities. Thus, the Chinese government began to shift its focus from purely large general hospitals development to primary community healthcare....   more»

»14/12/2009 [Industry news]
AlphaRx Inc. Appoints President for its China Operations

AlphaRx Inc. , an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs, has named Ruby Hui as President of China Operations....   more»

Pfizer »14/12/2009 [Company watch]
Pfizer, Takeda to promote diabetes drug in China

(Reuters) - Pfizer Inc the world\'s largest drugmaker, and Osaka-based Takeda Pharmaceutical Co Ltd 4502.T8 said on Tuesday they have signed an agreement to jointly promote and sell Takeda\'s diabetes drug in China....   more»

»12/12/2009 [Industry news]
Institut Merieux Plans China R&D Centre

Institut Mérieux, a French company that uses its expertise in industrial microbiology to serve medicine and worldwide public health, said it intends to create a center in China that combines R&D, bio-industrial and commercial activities....   more»

»12/12/2009 [Other]
China Industrial Production Surges as Trade Rebounds in Asia

Bloomberg: China industrial production jumped, exports fell the least in 13 months and imports surged in November as rebounding trade with Asian nations underscored the region’s role in leading the world recovery....   more»

»11/12/2009 [Company watch]
Pfizer, Crown Bioscience in R&D tie up for Asian Cancers

Pfizer (PFE) and Crown Bioscience, have entered into a collaboration to research and develop novel therapeutics for Asian cancers. Specific treatments for Asian cancers is said to represent an important unmet medical need as well as a significant market opportunity....   more»

»11/12/2009 [Industry news]
China Nepstar acquires Xiang Yun Kang Drugstore in Beijing

China Nepstar Chain Drugstore, the largest drugstore chain in China based on the number of directly operated stores, has entered into a definitive agreement with Beijing Xiang Yun Kang Drugstore, to acquire all of its six drugstores in Beijing....   more»

»11/12/2009 [Industry news]
Instem opens new full service office in Shanghai

Instem, a leading provider of early drug development software solutions, has announced the establishment of an office in Shanghai to provide local customer support, service delivery, client management, development and sales support to the Chinese pharmaceutical and wider life sciences R&D market....   more»

»11/12/2009 [Industry news]
China Yongxin\'s revenue decline by 29.8% in Q3 2009

China Yongxin Pharmaceuticals, Inc. (Yongxin), a leading pharmaceutical distributor and chain drugstore operator, announced that its net revenue totalled approximately $10.8 million for the three months ended September 30, 2009, a decline of 29.8percent from $15.5 million for the same period of 2008, due to lower sales from its wholesale business as result of a change in its sales strategy...   more»

Lotus Pharmaceuticals »11/12/2009 [Industry news]
Lotus Pharmaceuticals appoints Mr Jinzhong Han OTC division head

Lotus Pharmaceuticals, Inc. (Lotus), a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in China reported that effective December 1, 2009, Liang Fang, a controlled operating entity of Lotus, appointed Mr. Jinzhong HAN to be General Manager of the Company\'s Over-the-Counter Drug division (OTC Division)....   more»

»11/12/2009 []
China worries swine flu vaccine campaign faltering

China\'s vaccination campaign against the H1N1 flu strain is not proceeding as fast as it should be partly because people are needlessly worried about the safety of the vaccine, officials said on Friday...   more»

»11/12/2009 [Other]
China urged to revalue currency

(Reuters) - Senate Majority Leader Harry Reid urged Chinese President Hu Jintao to address his country\'s huge trade imbalance with the United States through a \"significant revaluation\" of China\'s currency....   more»

»10/12/2009 [Industry news]
Time wounds all healers- Shanghai adds years to training, medical grads unhappy

A new resident doctor training system planned for Shanghai may force new medical school graduates to undergo a three-year rotation in hospitals without offering official employment, according to China Youth Daily December 10....   more»

»08/12/2009 [Industry news]
Milestone Scientific Forms China JV for Injection Devices

Milestone Scientific Inc. (MLSS.OB) has launched a JV with China National Medicines Corporation Ltd. and Yichang Humanwell Pharmaceutical Co. Ltd., which will seek to develop orthopedic and epidural drug delivery instruments. Milestone, based in New Jersey, makes painless and precise injection devices, primarily for dental and dermatological use....   more»

»08/12/2009 [Other]
New smoking cessation guidelines aim to stop Chinese draggin\'

China will publish its latest edition of clinical smoking cessation guidelines in the near future, to assist medical personnel in providing smoking cessation services to patients....   more»

Bayer »07/12/2009 [Company watch]
Bayer Receives SFDA Approval For Betaferon To Treat Multiple Sclerosis

The Chinese State Food and Drug Administration (SFDA) has approved Bayer Schering Pharma\'s Betaferon (interferon beta-1b) therapy for patients with relapsing-remitting multiple sclerosis (MS). Bayer plans to launch Betaferon in China by mid 2010. Betaferon is available in more than 100 countries around the world....   more»

»07/12/2009 [Industry news]
The Week in Review

A week of activities in China Biotech industry...   more»

Wuxi Pharma Tech
»07/12/2009 [Company watch]
WuXi PharmaTech buys Labcyte product for High-Throughput Screening

WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and US, has announced that it has purchased a Labcyte POD 810 plate assembler equipped with an Echo 555 acoustic liquid handler for its work in high-throughput screening and secondary screening....   more»

»06/12/2009 [Company watch]
Concord Medical IPO Coming This Week

Concord Medical Services Holdings Ltd. (NYSE: CCM), a company that operates radiation therapy and diagnostic imaging centers in China, plans to raise $126 million for its IPO on December 10. The company claims to be the largest provider of radiotherapy and diagnostic imaging services in China....   more»

»04/12/2009 [Company watch]
Tianyin Pharma Calls for 75% Improvement in 2011

Tianyin Pharmaceutical, Co., Inc., (NYSE Alternext: TPI), a modernized TCM company, issued guidance calling for a 75% improvement in fiscal year 2011 (ending June 30, 2011) results. The company said it expects revenue of $113 million for fiscal 2011, up from $63.6 million in 2010, and net income of $19.6 million, a rise from $11.3 million in the current year....   more»

Simcere Pharmaceutical Group »03/12/2009 [Company watch]
Simcere Shuts Down Production in Rabies Vaccine Subsidiary over Quality Control

Simcere Pharmaceutical Group (NYSE: SCR) has stopped a production line at its recently acquired vaccine subsidiary while it reviews quality control systems in the company. Simcere bought a 37.5% stake in Jiangsu Yanshen Biological Technology Stock Co. in May, and then upped its ownership to just over 50% on October 24, 2009. It closed the production line on November 30....   more»

»03/12/2009 [Company watch]
AlphaRx Establishes Corporate Headquarters in Hong Kong and R&D Facility in Shanghai

AlphaRx Inc. (OTCBB: ALRX), today announced that it has selected locations in Hong Kong and Shanghai for its corporate headquarters and a new R&D facility respectively. This initiative will spearhead a major push into Greater China....   more»

»02/12/2009 [Industry news]
China Releases a New National Drug Reimbursement List

On November 30th, China’s MoHRSS (Ministry of Human Resources and Social Security) released the 2009 version of the National Drug Reimbursement List, which includes 260 new drugs, bringing it to a total of 2151 products. In the new list, all 307 members of the Essential Drug List are automatically included in the A class, which confers the highest levels of insurance reimbursement on these basic drugs. It was the first update of the Reimbursement List since 2004....   more»

AstraZeneca »01/12/2009 [Company watch]
AstraZeneca to Move Production of Raw Materials for Drugs to China

AstraZeneca plans to move all production of the vital molecules in its medicines offshore, mainly to China. The pharmaceuticals company’s cost-cutting drive, which will continue for some years, means that it will cease to produce or source active pharmaceutical ingredients (API) in the UK....   more»

»01/12/2009 [Company watch]
Tianyin Pharma (TPI) Gets Approvals from Chinese SFDA to Produce Two Generic Drugs

Tianyin Pharmaceutical Co., Inc., (AMEX: TPI) today announced that it has received approvals from the Chinese State Food and Drug Administration (SFDA) to produce Pediatric Fever and Cough Oral Liquid in dosage form of 10 ml/tube (SFDA approval number Z20093060) and Antibacterial and Anti-inflammatory Capsules in dosage form of 0.27 gram/capsule (SFDA approval number Z20090855)....   more»

»01/12/2009 [Company watch]
China Sky One to Sell Diagnostic Kits in Southeast Asia through Agent

China Sky One Medical, inc., a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in the people\'s republic of china (\"PRC\"), today announced that the company has engaged GuangDong Mediacy Kind Medical Devices Industry Service Company (\"MDK\") to serve as its exclusive sales agent for the company\'s Ami Diagnostic Kit and Human Urinary Albumin Elisa Kit in Southeast Asia....   more»

»01/12/2009 [Company watch]
FORMA Therapeutics closes Series B financing to a total of $25.5 million

FORMA Therapeutics, a pre-clinical stage Cambridge, MA biopharma, has closed a Series B financing that raised $25.5 million. The round was led by new investor Lilly Ventures, with participation from existing investors Novartis Option Fund and Bio*One Capital of Singapore. Current anti-infective drug discovery partner, Cubist Pharmaceuticals, Inc., joined as a new equity investor through a conversion of a previously-issued note. In conjunction with the financing, Steve Hall, Ph.D., a Venture Partner at Lilly Ventures, will join FORMA’s board of directors....   more»

»30/11/2009 [Industry news]
The Last Week in Review

Last week was an active one in the world of China life science. The Thanksgiving holiday in the US may have put a damper on the number of stories (it’s not clear why the slowdown happens, though it’s very apparent that it does). Nevertheless, the holiday was not enough to stop a number of very significant announcements. Most importantly there was news of additional R&D investments, a new private equity fund and a China life science company IPO filing....   more»

Wuxi Pharma Tech »30/11/2009 [Company watch]
WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year

WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company with operations in China and the United States, announced that it had been selected to the Deloitte Technology Fast 50 China 2009 list for the fifth consecutive year....   more»

»30/11/2009 [Company watch]
PPD Paid $77 Million to Acquire BioDuro

PPD, Inc. (NASDAQ: PPDI) today announced it has completed its acquisition of BioDuro LLC, a drug discovery outsourcing company focused on integrated drug discovery programs and services....   more»

»27/11/2009 [Company watch]
China Sky One Nears Approval on Two Diagnostic Tests

China Sky One Medical (NSDQ: CSKI) said it expects to have final SFDA approval for two more diagnostic kits by the end of 2009. One is a diagnostic test for Human Prostate Specific Antigen, an indicator of prostate related diseases, and the other is a determination kit for Luteinizing Hormone, a diagnosis test for female sterility....   more»

GlaxoSmithKline »27/11/2009 [Company watch]
GlaxoSmithKline and Gilead announce agreement to commercialise Viread® for chronic hepatitis B in key Asian countries

The companies’ combined commercialisation activities will expand access to tenofovir for the treatment of HBV, once approved, to patients in Asia where the prevalence in most countries is greater than 8 percent....   more»

»26/11/2009 [Company watch]
Pfizer Increases R&D Commitment in China

Pfizer (NYSE: PFE) will expand its China R&D operations by adding facilities in central and western China, according to a Reuters story. The company will build a new clinical R&D center in Wuhan, which will support global clinical drug programs, including Phase I-IV clinical trials. Pfizer did not announce the size of capital commitment to the new R&D center....   more»

»26/11/2009 [Company watch]
Sinovac Adds Vaccine Capacity by Forming JV

Sinovac Biotech (NSDQ: SVA) announced a new Joint Venture, Sinovac (Dalian) Vaccine Technology Co., Ltd., that will research, develop and produce human vaccines. Sinovac will contribute its vaccine expertise and capital, while Dalian Jin Gang Group will throw in land use rights, manufacturing facilities and established operating infrastructure. Representatives of Sinovac will fill the major operational posts in the JV....   more»

»25/11/2009 [Company watch]
Jiuding Launches Fund Targeting Pharmaceutical Industry; Specialization of Private PE Funds a New Trend

Kunwu Jiuding Capital Co., Ltd recently launched the first private equity investment fund targeting pharmaceutical industry in China - Kunwu Jiuding Pharmaceutical Investment Management Co., Ltd....   more»

Merck & Co
»25/11/2009 [Company watch]
Merck Serono to Spend $225 Million on New Beijing R&D Center

Merck Serono, a division of Germany’s Merck KGaA (MRK), will build a global R&D center in Beijing, China, spending $225 million over the next four years. The center, which will eventually house 200 employees, will be the fourth major R&D center for the company. The Beijing center will be tasked with meeting unmet needs in China’s public health system. Merck Serono positioned the center as proof of the company’s commitment to the pharmaceutical market in China....   more»

»25/11/2009 [Company watch]
China Nuokang Bio-Pharma Plans a Nasdaq IPO

China Nuokang Bio-Pharmaceutical, Inc., a Chinese drug company focused on hematological and cardiovascular products, has filed for a $69 million IPO of American Depository Shares (ADSs)....   more»

»23/11/2009 [Other]
Origin Agritech gets approval for GM Phytase Corn

Origin’s phytase corn is said to be the first transgenic corn to officially introduce the next generation of corn product approved and sold commercially into the domestic marketplace....   more»

»22/11/2009 [Industry news]
China Cord Blood Completes Secondary Offering on NYSE

China Cord Blood Corporation listed its ordinary shares on the New York Stock Exchange and, at the same time, completed a secondary offering....   more»

»22/11/2009 [Industry news]
China Biotech Week in Review: CROs Consolidating

From the past 7 days...   more»

»21/11/2009 [Other]
Cote d\'lvoire cooperates with China in fighting malaria

Cote d\'Ivoire is intensifying its cooperation with China in fighting malaria, \"the silent killer\" of children, health officials say with a joint venture underway in the West African country....   more»

Pfizer »20/11/2009 [Company watch]
Pfizer Is Best Positioned Big Pharma in China

In an investment review of Pfizer, Goldman Sachs said sales in emerging growth markets would become a significant factor in the company’s revenues, a fact that it considers underappreciated by stock market investors. China is the major emerging market for Pfizer....   more»

»19/11/2009 [Industry news]
Beijing health official refutes A/H1N1 vaccine suspension rumour

Beijing health authority said on Thursday that the A/H1N1 vaccine inoculation would not be suspended, dismissing a rumor circulating among the city\'s mobile phone subscribers....   more»

»19/11/2009 [Industry news]
Shanghai Fosun acquires 11% stake in Chindex International

Shanghai Fosun Pharmaceutical announced November 17 that it has acquired an 11% stake in Chindex International for USD 22 million through Fosun\'s subsidiary, Fosun Industrial Company,...   more»

»19/11/2009 [Company watch]
CROllup- PPD continues China acquisitions, will take over BioDuro

The deal is expected to be completed in the fourth quarter this year....   more»

»19/11/2009 [Industry news]
Tongjitang Chinese Medicines Reports Another Bad Quarter

The Q3 results from Tongjitang Chinese Medicines Company (NYSE: TCM) continue to show a decline in sales that has been going on for two years. Revenues dropped 5% lower in the quarter to $15.3 million, and net income moved from a $1.1 million profit in the year-earlier period to a $2 million loss....   more»

GlaxoSmithKline »19/11/2009 [Company watch]
GlaxoSmithKline Takes \'Three-Pronged\' Approach in China to Fight H1N1 Flu

GSK received approval of the drug in September from the SFDA. Relenza, like Tamiflu from Roche (RHHBY.PK), aims at reducing both the severity and the duration of flu symptoms, though some resistance to the drugs seems to be evident....   more»

»18/11/2009 [Industry news]
Jennerex Inks Deal with Lee\'s Pharmaceutical Holdings in China

Cancer medicine company Jennerex Inc. signed a deal with Lee’s Pharmaceutical Holdings Ltd. for development and sales of its lead drug....   more»

Wuxi Pharma Tech »17/11/2009 [Company watch]
WuXi Pharma Feels the Worst of the Downturn Is Over

WuXi PharmaTech , a bellwether for China’s CRO industry, reported a modest increase in Q3 revenues, but clearly feels the worst of the economic downturn is in the past....   more»

»16/11/2009 [Finance]
Foreign-invested Companies Allowed to List on China Stock Market

In order to expand fields of Sino-foreign cooperation, encourage new investment modes and optimize the structure of foreign investment, China will gradually reduce limits on the equity stake proportion allowed to overseas investors....   more»

»16/11/2009 [Industry news]
China orders Sinovac\'s Hepatitis A vaccine Healive

Sinovac Biotech has been selected by the Shanghai Government to supply its inactivated hepatitis A vaccine, Healive, to the public market of Shanghai....   more»

»16/11/2009 [Finance]
Markets bet on yuan rise despite China rebuff

Offshore markets bet on hefty yuan gains over the next year even after Beijing rebuffed calls for the currency to rise, signalling resistance to change during U.S. President Barack Obama\'s first visit to China....   more»

»16/11/2009 [Finance]
Strauss-Kahn Says China Currency Still Undervalued

It is in the interest of the Chinese people for the yuan to appreciate, Strauss-Kahn said today at an event in Beijing. The appreciation of the yuan is part of the “package of necessary reforms” for China’s economy, he said in an earlier speech in Beijing today....   more»

Novartis »16/11/2009 []
Novartis Says Weak IP Protection Makes India R&D Impossible

Novartis once again said that India is not a place to do R&D because its IP laws are not strong enough to protect discoveries. In 2006, Novartis made a commitment to build a $125 million R&D facility in Hyderabad....   more»

»16/11/2009 [Industry news]
China Pharma Results

5 companies post their results...   more»

»16/11/2009 [Industry news]
Stirling reports increase of sales in Mongolia

Australian healthcare company Stirling Products has announced that the sales of the company’s products through its test marketing initiative in Mongolia have continued to steadily grow....   more»

»13/11/2009 [Industry news]
Undersea probe may help produce new medicines

(Xinhua) -- Chinese scientists said Tuesday China s ongoing undersea probe of a sulfide deposit could help produce new medicines by studying the submarine hydrothermal organisms....   more»

»13/11/2009 [Industry news]
HUYA Bioscience partners with Ocean University

The agreement is said to be another in a series of collaborations that HUYA has established with China\'s leading research and development institutions to enable and accelerate the global development and commercialization of novel biopharmaceutical product opportunities originating in China....   more»

Wuxi Pharma Tech
»13/11/2009 [Company watch]
WuXi Pharma Planning New Facility for R&D Services

WuXi PharmaTech has signed a letter of intent with the Wuxi Outsourcing Area for Bio-Medical Research and Development to establish a facility that will provide R&D services. So far, WuXi PharmaTech has not made a formal announcement of the LOI, though company officials did confirm its existence...   more»

»13/11/2009 [Company watch]
Novartis to acquire majority stake in HTDS Chinese subsidiary

Hard To Treat Diseases has announced that Novartis is acquiring an 85 percent stake in HTDS\' H1N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmaceutical, for $125 million....   more»

Pfizer »11/11/2009 [Industry news]
BMP Sunstone Partners with Pfizer to Distribute Endometriosis Treatment in China

BMP Sunstone Corporation and Pfizer China (NYSE: PFE) have formed a strategic partnership to distribute and promote Depo-Provera (Medroxy-progesterone Acetate), a Pfizer product used to treat endometriosis, in China....   more»

»10/11/2009 [Company watch]
Pfizer Cutbacks Reflect Difficulties Facing Big Pharma

Pfizer announced it would close six out of its 20 R&D facilities around the globe...   more»

»09/11/2009 [Other]
The Three Gorges Project Months From Completion

The mammoth undertaking of 17 years will conclude at the end of 2009....   more»

Simcere Pharmaceutical Group »09/11/2009 [Company watch]
Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced an agreement to acquire the manufacturing license in China of Rosuvastatin from Tianjin Tianda Pharmaceutical Co., Ltd....   more»

»09/11/2009 [Company watch]
JOINN Takes Big Leap into China CRO Future

JOINN Laboratories has a very specific vision of the future for CROs in China. “We expect a huge increase in demand for CRO services,” said John Gong, PhD, VP and CTO of JOINN in an exclusive interview with ChinaBio® Today. “In the near future, pharma will outsource 75% of its pre-clinical work, up from a level of about 25% today.”...   more»

»08/11/2009 [Industry news]
The Last 7 days in China Bio Industry

Major Investments in China Biotech Companies...   more»

»08/11/2009 [Industry news]
Biostar Raises $3.6 Million

Biostar will use the proceeds to complete its new raw materials processing facility....   more»

»08/11/2009 [Industry news]
D-Pharm in China stroke drug deal with Wanbang

Israeli biopharmaceutical firm D-Pharm said on Sunday it has signed a deal with Wanbang Biopharmaceuticals to jointly develop and distribute its stroke prevention treatment in China....   more»

»08/11/2009 [Other]

The Chinese economy is expected to have gathered steam in October, adding momentum to the Asian recovery....   more»

»08/11/2009 [Industry news]
China health ministry to launch web spokesman

China Ministry of Health is preparing for the launch of a web spokesman to better inform the public, explain policies and respond timely to questions...   more»

»06/11/2009 [Industry news]
ScinoPharm breaks ground for Changshu Plant

ScinoPharm, a leading global supplier of active pharmaceutical ingredients (APIs), has commenced construction of a new plant on a 66670 square meter site. The facilities, located in Changshu, Jiangsu province in China, is expected to include a R&D centre and production plants fully compliant with US and international GMP standards....   more»

»06/11/2009 [Industry news]
Beike Biotech invests in Japanese company

Shenzhen Beike Biotechnology, China\'s leading stem cell research and regenerative medicine company, has entered into an agreement with Yokohama-based Biomaster for investment in its advanced technologies....   more»

»06/11/2009 [Industry news]
Histostem provides Hematopoietic stem cell to hospital

Stem Cell Therapy International and its soon to be subsidiary, Histostem of South Korea, announced that they have supplied hematopoietic stem cells to The Queen Mary Hospital of the University of Hong Kong, China, for treatment of Leukemia patients....   more»

Roche »05/11/2009 [Industry news]
Roche Opens Singapore Manufacturing Facility for Projects Initiated by Genentech

Roche has opened a new $500 million biologics manufacturing facility in Singapore in the Tuas Biomedical Park....   more»

»05/11/2009 [Industry news]
U.S. biotech firm opens biotechnology research centre in China

The U.S. Monsanto Company announced here Thursday that it has opened its first research centre in China....   more»

»04/11/2009 [Company watch]
Novartis buys China vaccine stake for $125 mln

Swiss drugmaker Novartis is buying an 85 percent stake in privately owned Chinese vaccines company Zhejiang Tianyuan...   more»

»04/11/2009 [Industry news]
Monsanto Company (MON) Opens First Biotechnology Research Center in China

Monsanto Company announced today that it is opening its first research center in China, further demonstrating its commitment to forming technology collaborations in the country....   more»

»04/11/2009 [Industry news]
AGA Medical Corporation Receives Product Approvals in China

AGA Medical Holdings has received regulatory approvals and licenses in China for its AMPLATZER® PFO Occluder and AMPLATZER® Multi-Fenestrated Septal Occluder Cribriform....   more»

»03/11/2009 [Company watch]
Novartis International AG to Invest $1 Billion in China

Novartis announced today a USD 1 billion investment over the next five years, increasing R&D activities in China and confirming Novartis\' long term commitment to China\'s further economic development, health reform and improving the health care of the Chinese people....   more»

»03/11/2009 [Industry news]
NeoStem, Inc. Closes China Biopharma Acquisition

NeoStem, Inc. announced it has closed its acquisition of China Biopharmaceuticals Holdings,...   more»

Charles River »03/11/2009 [Company watch]
Charles River Announces Third-Quarter 2009 Results

* Sales Decrease 13.1% to $297 Million...   more»

»02/11/2009 [Other]
H1N1 flu \'spreading but under control\'

The A(H1N1) influenza was spreading rapidly across the country but it remained under control, an official with the Ministry of Health said here Sunday. \"Currently close to 80 percent of the country\'s total flu infections are A(H1N1) flu cases, though the state of the flu was still mild and there was no evidence of virus mutation,\" Liang said....   more»

»02/11/2009 [Industry news]
The Past Week in Review

A week of activities in China Bioindustry...   more»

»31/10/2009 [Industry news]
China\'s Nasdaq-style market makes strong debut

China\'s ChiNext stock market , a long-awaited Nasdaq-style second board that aims to turn local start-up firms into budding Microsofts or Intels, kicked off trading on Friday with strong gains, in line with expectations.The first batch of 28 companies made their listing debut on ChiNext, part of the Shenzhen Stock Exchange in southern China, with share price gains of 46 percent to 123 percent at the opening compared with their initial public offering prices....   more»

Sanofi-Aventis »30/10/2009 [Company watch]
Sanofi-Aventis enters China’s OTC market

Sanofi-Aventis has signed a joint venture agreement with Minsheng Pharmaceutical Group of Hangzhou to exploit the country’s booming OTC vitamin and mineral market. China’s OTC market is predicted to become the world\'s second largest OTC market in 2010, according to Olivier Charmeil, Sanofi-Aventis\' senior vice president for pharmaceutical operations in Asia/Pacific and Japan....   more»

»29/10/2009 [Company watch]
Tianyin Pharma Creates New Antibiotic JV

Tianyin Pharmaceutical, Co., Inc., (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine (\"TCM\") based in Chengdu, China , today announced it has formed a joint venture with Sichuan Mingxin Pharmaceutical Co., Ltd (\"Mingxin\") named Sichuan Jiangchuan Pharmaceutical Co., Ltd. (\"Jiangchuan\"). Tianyin owns 77% of Jiangchuan and will utilize this as the foundation for a broader, longer term strategy to build a significant presence in the rapidly growing Chinese macrolide antibiotics market, while diversifying its revenue base of western pharmaceuticals...   more»

»28/10/2009 [Company watch]
China Medicine announces acquisition of Guangzhou LifeTech Pharmaceuticals

China Medicine Corporation (OTC Bulletin Board: CHME) (\"China Medicine\" or \"the Company\"), a developer and leading distributor of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines (\"TCM\"), nutritional and dietary supplements, and medical devices and medical formulations, today announced that through its wholly-owned subsidiary in China, Konzern Pharmaceuticals, it has signed an equity transfer agreement (the \"Transfer Agreement\") to acquire 100% of equity interests in Sinoform Limited (\"Sinoform\"), a British Virgin Islands corporation, the sole shareholder of Guangzhou LifeTech Pharmaceuticals Co. Ltd. (\"LifeTech\"), a wholly-owned subsidiary of Sinoform. LifeTech is a developer, manufacturer and marketer of pharmaceuticals products and TCMs headquartered in Guangzhou, the People\'s Republic of China (\"PRC\")....   more»

Simcere Pharmaceutical Group »28/10/2009 [Company watch]
Simcere Gains Majority Control of Vaccine Subsidiary

Simcere Pharmaceutical Group (NYSE: SCR), a China company that makes branded generic and proprietary pharmaceuticals, now controls a majority 50.77% of its vaccine subsidiary, Jiangsu Yanshen Biological Technology Stock Co., Ltd. Simcere bought its original 37.5% stake in Jiangsu Yanshen in May 2009....   more»

»28/10/2009 [Company watch]
PPD buys CRO, creates spin-offs and invests $100M in Celtic

PPD has pulled off a triple play, announcing in a string of releases that it acquired a large contract research organization in China, plans to invest $100 million in Celtic Therapeutics as it sets the stage for a strategic alliance, and is spinning off its compound partnering business into two new companies....   more»

»27/10/2009 [Company watch]
Sinovac Obtains Third H1N1 Vaccine Order from Chinese Central Government

Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that it has received its third purchase order for its H1N1 vaccine, PANFLU.1, from China\'s MinIStry of Industry and Information Technology for the national stockpiling plan. Under this purchase order, Sinovac is required to produce an additional 5.19 million doses of PANFLU.1 (15ug/0.5ml) for the Chinese central government. Out of today\'s announced PANFLU.1 order, Sinovac is required to complete delivery of 2.89 million doses to the appointed provincial and municipal governments by the end of this year and supply the remaining 2.3 million doses for the central government stockpiling....   more»

»26/10/2009 []
China Absorbs Overseas Talent

CHINA\'S appetite for resources has extended to people, creating quite a buzz in global human capital circles. At the end of December 2008, 27 Shanghai-based financial institutions conducted a recruitment trip to London, Chicago and New York, putting 170 mid- or high-level positions on the block. During the 10-day trip, they interviewed about 4,000 applicants on site, and some 800 were later sporting their memoranda of agreement with the firms....   more»

»26/10/2009 [Other]
Public cringes at vaccine shot

More than 54 percent of Chinese people do not plan to receive the A/H1N1 flu vaccine because they doubt its safety and quality, according to a new survey by China Daily and major portal   more»

»26/10/2009 [Industry news]
Expert sees big health market in China

China, though with increasing number of obese people, has the greatest opportunity to lead the wellness industry in the world, said Paul Zane Pilzer, the wellness theory founder and former economic adviser to two US presidents....   more»

»26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says

China’s growth will remain (fast) in the fourth quarter as economies recover around the world and as investor and consumer confidence returns, a National Bureau of Statistics official said today...   more»

»26/10/2009 [Industry news]
China-Biotics CFO resigns

China-Biotics, has announced that Mr Lewis Fan has resigned as Chief Financial Officer in order to pursue other professional interests....   more»

»26/10/2009 [Industry news]
Investigator Meetings Completed in Japan and China for Celsion Corporation Global Phase III ThermoDox(R) Trial

Celsion Corporation announced today that it has completed a critical regulatory step in the countries of China and Japan to rapidly enroll patients in its global Phase III ThermoDox trial for the treatment of Hepatocellular Carcinoma (HCC), also known as primary liver cancer....   more»

MPI Research »26/10/2009 [Company watch]
Medicilon/MPI Preclinical Research-Shanghai Receives AAALAC Certification

Medicilon/MPI Preclinical Research-Shanghai has been recognized as an accredited International Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) facility. This accreditation further underscores the company’s commitment to quality research. The AAALAC initiative was led by Lijie Fu, PhD, Executive Vice President of Operations, a national returnee with substantial industry, scientific and CRO experience....   more»

»25/10/2009 [Industry news]
Review of the last week

Activities in the BioPharma industry...   more»

»24/10/2009 [Industry news]
30% of China\'s Hepatitis B patients can\'t afford long-term treatment

Nearly 30 percent of Hepatitis B patients in China do not stick to long-term medical treatment or take medicine less frequently than they should due to lack of money, according to a survey published here Friday....   more»

»24/10/2009 [Industry news]
China predicted to become world\'s second largest OTC medicine market in 2010

China will become the world\'s second largest market of non-prescriptive medicine, or over the counter(OTC) medicine in 2010, says Olivier Charmeil, Sanofi-Aventis...   more»

»23/10/2009 [Industry news]
China to rein in fake drug ads in cyber space

China will launch a one-year crackdown on fake drug ads on the Internet and sales of fake drugs through postal services, according to a cross-ministerial meeting here Friday....   more»

»23/10/2009 [Industry news]
Perverse incentives: pharmacies pulling essential drugs from shelves

Certain national essential drugs were taken off the shelves in Chongqing City retail pharmacies in response to the implementation of new essential drug guiding prices October 22, according to Chongqing Evening News....   more»

»23/10/2009 [Industry news]
BioTime Investigates Stem Cells to Treat Cancer

BioTime licensed its cell-based cancer therapy technology, including early patent filings on using stem cells to target malignant tumors, to the new subsidiary....   more»

»23/10/2009 [Industry news]
Jiangbo COO resigns

Jiangbo Pharmaceuticals has announced the resignation of Mr Haibo Xu, the Company\'s Chief Operating Officer (COO), effective October 20, 2009....   more»

Wuxi Pharma Tech
»23/10/2009 [Industry news]
WuXi PharmaTech appoints Dr Hui Cai as VP of Business Development

Dr Hui Cai has been appointed as Vice President of Business Development. She will report directly to Dr Richard M. Soll, Senior Vice President of Integrated Services....   more»

»23/10/2009 [Industry news]
China-Biotics, Inc. Announces Changes to Management Team

China-Biotics, Inc. , a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced that Lewis Fan has resigned as Chief Financial Officer in order to pursue other professional interests....   more»

»22/10/2009 [Industry news]
NEDL price list goes into effect, price decreases seen for many drugs

The guiding prices for drugs on the national essential drug list (NEDL) became effective October 22, according to October 21. 2,349 specifications for 296 types of national essential drugs received guiding prices....   more»

»22/10/2009 []
Sinovac Biotech Ltd. (SNVBF) Receives Certificate of Approval to Distribute PANFLU.1 (H1N1) in Mexico

Sinovac Biotech Ltd. today announced that it has received a Certificate of Approval from the Secretaria de Salud to distribute PANFLU.1, its H1N1 pandemic influenza (swine flu) vaccine, in Mexico....   more»

»22/10/2009 [Company watch]
Mycenax Finishes Phase II Trial of Biosimilar Drug

Protein drug development company Mycenax Biotech Inc. (GreTai, Taiwan: 4726) announced today that its rheumatoid arthritis and psoriasis drug TuNEX®, a biosimilar version of etanercept, has successfully completed a Phase I trial in South Korea and a Phase I/II clinical trial in Taiwan is in the data analysis and report preparation stage; important clinical trial milestones towards the commercial release of the drug in both regional and global markets....   more»

»21/10/2009 [Industry news]
Experts study thriving HIV (controllers) in vaccine search

AIDS researchers want to expand their study of a rare group of HIV-infected people, whose immune systems naturally and mysteriously prevent the virus thriving in their bodies, to span the globe....   more»

»21/10/2009 [Other]
France AXA to exit investment in Chinese insurer

French insurer AXA is in the early stages of selling its 15 percent stake in China\'s Taikang Life Insurance Company, in a deal that could fetch as much as $1 billion, sources said on Thursday....   more»

»21/10/2009 [Industry news]
China Biologic Products Named to Forbes Magazine Fifth Annual List of Asia\'s 200 Best Under a Billion

China Biologic Products, Inc. one of the leading plasma-based pharmaceutical companies in China, today announced that the Company was named on Forbes Magazine\'s fifth annual list of Asia\'s \"200 Best Under a Billion\" for the year 2009....   more»

»20/10/2009 [Industry news]
1st domestic liposomal peg-doxorubicin enters market

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical announced October 18 that it has introduced its cancer treatment injection, pegylated doxorubicin HCl liposome injection, to the market, according to   more»

»20/10/2009 [Industry news]
China Medical Wins SFDA Approval for Molecular Biology Biosensor

China Medical Technologies, Inc. reported it received SFDA approval for its Surface Plasmon Resonance (SPR) diagnostic technology, a molecular biology biosensor. China Medical Technologies has developed SPR as a diagnostic test for human papillomavirus (HPV), a common virus that causes warts and can ultimately cause cervical cancer. One year ago, China Medical paid a very substantial $345 million to acquire the technology....   more»

Simcere Pharmaceutical Group »20/10/2009 [Company watch]
Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals

Simcere Pharmaceutical Group a leading pharmaceutical company specializing in development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced an agreement with OSI Pharmaceuticals, Inc., to develop, manufacture, and market its KDR/Kit inhibitor OSI-930 in China....   more»

»19/10/2009 [Industry news]
See new Nov Event

...   more»

»18/10/2009 [Industry news]
China Pediatric Completes a Reverse Merger

China Peadiatric Pharmaceuticals, Inc. (LHSI.OB) has completed a reverse merger, taking over the company formerly known as Lid Hair Studios International. China Pediatric Pharma, which is headquartered in Xi’an, produces and distributes prescription and OTC drugs for children, some of which are western and the rest based on TCM....   more»

»18/10/2009 [Industry news]
A Week of Activity in the China Bio Industry

Seven days of industry action...   more»

»18/10/2009 [Industry news]
Celsion Is Granted SFDA Approval for China Cancer Trial

Celsion Corporation has received SFDA approval to include China sites in its global Phase III clinical trial of a new liver cancer therapy, ThermoDox....   more»

»18/10/2009 [Industry news]
China Medical Technologies, Inc.announces the SFDA Approval for its SPR System

China Medical Technologies, Inc. today announced that the Company has received approval for its SPR- based analysis system (the \"SPR System\") from the State Food and Drug Administration of China....   more»

»17/10/2009 [Finance]
Asian Recovery to Lead Any Global Trade Growth, WTO Chief Says

Asian countries that manufacture low-priced goods are likely to lead any recovery in global cross-border commerce as the recession wanes, World Trade Organization Director General Pascal Lamy said....   more»

»16/10/2009 [Industry news]
Celsion phase III ThermoDox trial approved by SFDA

US-based Celsion Corporation has received official approval from the China State Food and Drug Administration for its ThermoDox Clinical Trial Application....   more»

Sundia MediTech Company,Ltd. »16/10/2009 [Company watch]
Sundia appoints Senior VP of Sales and Marketing

Sundia MediTech, a leading pharmaceutical R&D outsourcing service company in China, has announced that Mr Charles D Maher has been appointed Senior Vice President of Sales and Marketing of Sundia....   more»

»16/10/2009 [Industry news]
Mitsibishi, Medipal ally with Sinopharm

Japanese trader Mitsubishi, pharma retailer Medipal have teamed up with Shanghai-based Chinese pharma distributor Sinopharm to enter China...   more»

»15/10/2009 [Industry news]
DIA to host first China meeting in Beijing on Nov 1-3

The Drug Information Association (DIA), in collaboration with the China Center for Pharmaceutical International Exchange of the SFDA, will host the First China Annual Meeting: Drug Development in a Flat World—Innovation, Regulation and Globalization in Beijing, China....   more»

»14/10/2009 [Industry news]
Biostar Pharma Wins Patent for Second Hepatitis B Product

Biostar Pharmaceuticals, received a China patent for Aoxing Ganbao, an external use TCM treatment for hepatitis B....   more»

»12/10/2009 [Company watch]
GlaxoSmithKline Forms Vaccine JV for the China Market

GlaxoSmithKline has formed a JV with Jiangsu Walvax Biotech Company to develop and manufacture pediatric vaccines for the China market. Initially, the JV will be funded with $65.6 million of capital, of which $32 million (65%) will come from GSK. GSK has also agreed to provide an additional $11.6 million in 2015. The agreement contains provisions allowing both companies to increase their stakes in the future....   more»

»12/10/2009 []
China Biotech

A Week of activities in the China Bio Industry...   more»

China Biopharmaceuticals Holdings »12/10/2009 [Company watch]
NeoStem, Inc. Confirms Acquisition of China Biopharmaceuticals Holdings, Inc. and a Controlling Interest in Leading Chinese Pharmaceutical Company

NeoStem, Inc., which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today that the United States Securities and Exchange Commission has declared effective its Registration Statement on Form S-4 filed with the Commission....   more»

»12/10/2009 [Company watch]
Merial Invests $70 Million in Nanchang, China

Merial, the Animal Health division of the sanofi-aventis Group, announced today that Merial Animal Health Co. (China) held a ground-breaking ceremony for an expansion project at its plant located in the Nanchang Hi-tech Development Zone, China. Merial Animal Health Co. (China), a venture of Merial Limited and the Group\'s first production facility in China has been in operation for almost 20 years....   more»

»09/10/2009 [Industry news]
NeoStem Moves Ahead with China Biopharma Acquisition

NeoStem reported the SEC accepted its registration proposal to acquire China Biopharmaceutical Holdings (CHBP.OB) in an all-stock transaction....   more»

»09/10/2009 []
Sinobiopharma gets Chinese SFDA approval for use of Gabexate Mesylate

Sinobiopharma, a fully integrated and highly innovative specialty biopharmaceutical company engaged in the research and development, manufacture and marketing of biopharmaceutical products in China has received a certificate for the use of Gabexate mesylate as a pharmaceutical raw material from the Chinese State Food and Drug Administration...   more»

Charles River
»08/10/2009 [Company watch]
Charles River Shanghai Facility Wins Animal Care Accreditations

Charles River reported that its year-old Shanghai CRO facility has received three accreditations from organisations protecting the care of laboratory animals: the Association for Assessment and Accreditation of Laboratory Animal Care ((AAALAC)), the Canadian Council on Animal Care (CCAC) and the Shanghai Laboratory Animal Commission (SLAC)....   more»

»05/10/2009 [Industry news]
China Biotech Week in Review

China Biotech Review in the past week...   more»

»05/10/2009 [Other]
Rabies grave threat to Chinese peoples safety: ministry

At least 40 million people are attacked by animals every year on the Chinese mainland, based on the quantity of rabies vaccine used, according to a recent report on rabies\'s prevention and treatment....   more»

»02/10/2009 [Industry news]
China to Cut Medicine Prices in Late October

China will cut prices for nearly half of its essential drugs by 12 percent on average on October 22, said the National Development and Reform Commission (NDRC) Friday....   more»

Eli Lilly & Co
»02/10/2009 [Company watch]
Eli Lilly will Double China Workforce

Eli Lilly plans to double its workforce inside of China this year, bringing the total up to 2,000. At the same time, the company announced a 5,500 employee reduction in its worldwide staff count that will help trim $1 billion in annual costs....   more»

Wyeth »01/10/2009 [Company watch]
China Requires One Divestiture for Pfizer / Wyeth Merger

The Anti-Monopoly Bureau of China’s Ministry of Commerce ((MOFCOM)) has given its okay to the merger between Pfizer (NYSE: PFE) and Wyeth (NYSE: WYE). However, MOFCOM will require that Pfizer divest its swine mycoplasmal pneumonia vaccine business. Pfizer has been negotiating with the Anti-Monopoly Bureau on the ruling, implying that it will not be surprised by the ruling, even if it may not agree....   more»

»01/10/2009 [Industry news]
New Patent Rules Take Effect on October 1

The Third Amendment to China’s Patent Law takes effect today, October 1, 2009. From the inception of China patent law twenty-five years ago in 1984, the system has undergone two previous revisions. In late December 2008, after several years of debate and three proposed drafts, the final draft of the Third Amendment was accepted. Now, nine months after passage, the new rules have become the law....   more»

»01/10/2009 [Industry news]
Sinobiopharma appoints Mr Xinjie Mu as its new CFO

Sinobiopharma, has appointed Mr. Xinjie (James) Mu as the new Chief Financial Officer and as a director on the Board. Dr. Lequn Huang resigned as the Chief Financial Officer in order to make room for the appointment of Mr. Mu....   more»

Merck & Co »30/09/2009 [Company watch]
Merck Acquires Leading Manufacturer of Effect Pigments in China

Within the scope of this transaction, Merck has acquired the production site of Taizhu in Taicang, 40 km from Shanghai, as well as the entire sales and marketing organization in China and abroad for a total consideration of € 28 million....   more»

»30/09/2009 [Company watch]
Sinovac Obtains Second Order of H1N1 Vaccine from Chinese Central Government

Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that Sinovac has received its second purchase order for its H1N1 vaccine, PANFLU.1, from the Ministry of Industry and Information Technology of the People\'s Republic of China for the national stockpiling plan. Under this purchase order, Sinovac is required to produce an additional 3 million doses of PANFLU.1 (15ug/0.5ML), Sinovac\'s H1N1 vaccine for the central government....   more»

»29/09/2009 [Industry news]
Output Value of China Pharmaceutical Industry to Top CNY 1 Trillion

The output value of China\'s pharmaceutical industry is expected to top CNY 1 trillion this year, ranking seventh globally, according to a recent report released by the Chinese Pharmaceutical Enterprises Association....   more»

Tianjin Institute Of Pharmaceutical Research—Ne »28/09/2009 []
Tianyin Pharma reports 28.2% increase in sales in fiscal 2009

Tianyin Pharmaceutical Co., a developer, manufacturer and supplier of modernized traditional Chinese medicine (TCM) and generic pharmaceuticals in China, reported that for the fiscal year ended June 30, 2009, its revenues have increased 28.2% to $42.9 million from $33.5 million reported for the prior year period....   more»

»28/09/2009 []
QRxPharma enters into alliance with Nuokang to develop Venomics assets

QRxPharma Limited, a clinical-stage specialty pharmaceutical company from Australia announced a strategic alliance with Liaoning Nuokang Medicines Co. Ltd. (Nuokang), a Chinese biopharmaceutical company based in Shenyang to develop and commercialize QRxPharma\'s venomics assets for the Chinese market...   more»

»28/09/2009 [Other]
Health Ministry: Rabies poses major health threat

Rabies has become one of the biggest public health risks facing China, with more than 2,400 people killed each year, the Ministry of Health has warned....   more»

»28/09/2009 [Company watch]
Health Robotics Announces SINOPHARM Deal

The company announced an exclusive five-year strategic agreement with China National Pharmaceutical Foreign Trade Corporation (SINOPHARM Foreign Trade), which will distribute and support the company\'s CytoCare and i.v.STATION Robots....   more»

»28/09/2009 [Company watch]
KYORIN and Eisai Sign License Agreement for Development and Marketing of Uritos Tablets in China, India, Sri Lanka and ASEAN Countries

KYORIN Pharmaceutical Co., Ltd., a subsidiary of KYORIN Co., Ltd., and Eisai Co., Ltd. announced today the conclusion of a license agreement for Uritos(R) Tablets (generic name: imidafenacin), a therapeutic agent for overactive bladder, discovered and developed by KYORIN. Under the terms of this agreement, KYORIN shall grant Eisai the exclusive rights to develop and market the agent in China, India, Sri Lanka and ASEAN countries (\"licensed territory\")....   more»

»28/09/2009 [Company watch]
Zhangjiang Hi-Tech Park VC Unit to Buy Stake in Buchang

Shanghai Zhangjiang Hi-Tech Park Development Co. said it will increase its investment in wholly-owned subsidiary Haocheng Venture Capital Co. by 48 million yuan to help Haocheng buy a 0.4 percent stake in Shandong Buchang Pharmaceutical Co....   more»

»27/09/2009 []
Biotech - A week in Review

Activities in the China Bio-Pharma industry...   more»

»27/09/2009 [Other]
FACTBOX: Five risks to watch in China

* GOVERNMENT STABILITY China\'s government has so far maintained widespread popular support without major political change. Predictions that the global crisis could spark widespread unrest among laid-off workers have not materialized. Outbreaks of unrest have remained localized, and ethnic tensions in Tibet and Xinjiang have not seriously threatened stability. Calls from some activists and intellectuals for greater openness and democracy have not so far gained much popular traction. But China\'s political stability is a crucial issue for global markets, and any change to assessments of stability would have a major impact....   more»

»27/09/2009 [Company watch]
China Sinochem bids $2.5 billion for Australia Chemical Co Nufarm

(Reuters) - Chinese state-owned Sinochem bid $2.5 billion for Australian farm chemicals group Nufarm Ltd (NUF.AX) on Monday, looking to gain a global footprint in a deal that could again test investment ties between China and Australia....   more»

Simcere Pharmaceutical Group »25/09/2009 [Company watch]
Simcere Teams Up with Cancer Centre to Develop Drugs

Simcere Pharmaceutical Group and Sun Yat-Sen University Cancer Center of Guangzhou have established a strategic relationship to develop cancer drugs....   more»

»25/09/2009 [Industry news]
CP Lab Safety Returns Manufacturing to U.S. From China

CP Lab Safety, a leading maker of environmentally friendly laboratory safety products, announced today that it has begun manufacturing its line of more than 80 products in the United States, after producing its goods in China for more than seven years....   more»

»25/09/2009 [Industry news]
West Pharmaceutical Services Dedicates Injection Moulding Plant in China

West Pharmaceutical Services, Inc. , the global leader in innovative solutions for injectable drug administration, today announced the formal opening of its injection molding factory in the Shanghai Qingpu Industrial Zone (SQIZ) in China....   more»

»24/09/2009 [Industry news]
China Biologic Products Enters into a Strategic Research and Development Agreement with IBT of CAMS

China Biologic Products, Inc. one of the leading plasma-based pharmaceutical companies in China , today announced that on September 11, 2009, the Company entered into a strategic research and development agreement with the Institute of Blood Transfusion based in Chengdu, Sichuan Province, to strengthen the Company\'s research and development capabilities and manufacturing processes....   more»

China Aoxing Pharmaceutical Company, Inc. »24/09/2009 [Company watch]
China Aoxing Awarded Centre of Excellence in Enterprise Technology

China Aoxing Pharmaceutical Company, Inc. a China-based pharmaceutical company specialising in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that China Aoxing honourably received Centre of Excellence Award in Enterprise Technology by the consortium of China local government offices....   more»

»24/09/2009 [Independent reports]
Clinical development trends in APAC in recessionary environment

With ‘green shoots’ (recovery from the economic downturn) appearing in the global economy, it is a good time to consider what is happening in the Asia Pacific (APAC) biopharma scene. Dr Ross Horsburgh...   more»

»24/09/2009 [Industry news]
BioTime Faces Daunting Conditions to Set Up China Stem Cell Subsidiary

BioTime, Inc. will establish a China subsidiary, called BioTime Asia, to market the company’s stem cell products in China and throughout Asia. The company will also use its technology to develop stem cell therapies aimed at treating a number of diseases, including the use of genetically modified stem cells to treat currently incurable forms of cancer. BioTime has engaged the services of Dr. Lu Daopei, a prominent China heamatologist, to help set up and manage the clinical trials of its therapeutic stem cell products....   more»

»24/09/2009 [Company watch]
CNPG + CNBG = CNPG (Sinopharm name to remain unchanged post-merger)

The merged entity of China National Pharmaceutical Group (Sinopharm) and China National Biotech Group (CNBG) will maintain the China National Pharmaceutical Group name....   more»

»22/09/2009 [Industry news]
NiTi Surgical Solutions Announces Issuance of Patents in China

NiTi Surgical Solutions, an innovative surgical device company, today announced the Japan Patent Office and the Patent Office of China have issued patent certificates that cover two of the company’s products...   more»

»21/09/2009 [Other]
RBS Names Xiang, Yin Co-Heads of China Investment Banking

Royal Bank of Scotland Group Plc said it appointed Joe Xiang and Raymond Yin as co-heads of China investment banking. Jinfeng Ben was named head of local corporates for China, RBS said in an e-mailed statement....   more»

»21/09/2009 [Independent reports]
Biotech Companies with Developing Country Partners Better Positioned to Innovate and Thrive

Collaboration with health biotech companies in developing countries represents a major opportunity for companies in developed countries to strengthen their market reach and innovation potential, according to the findings of a new study. By BiotechDaily International staff writers...   more»

Eli Lilly & Co »21/09/2009 [Company watch]
Eli Lilly to Double China Workforce

Monday, September 21, 2009 David Ricks, president of Eli Lilly China, announced that although Eli Lilly will cut 5,500 jobs in the US, it will double its positions in China to over 2,000,...   more»

»20/09/2009 [Industry news]
China Bio Industry over the past week

The last seven days of activities...   more»

»20/09/2009 [Industry news]
Genzyme Pushes to Expand Product Line in China

Genzyme Corp. (has begun building its $100 million R&D center in Beijing, according to an article in The China Daily. The center, which will eventually employ 350 people, will comprise 200,000 square feet (18,580 square meters) and is expected to be completed in 2011. It will seek to discover and develop novel biologics and other gene therapies....   more»

»18/09/2009 [Industry news]
China Medical Technologies Announces US$30 Million Share Repurchase Program

China Medical Technologies, Inc., a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that its board of directors approved a share repurchase program on September 17, 2009....   more»

Tianjin Institute Of Pharmaceutical Research—Ne »18/09/2009 [Company watch]
Tianyin Pharma Granted GMP for New Solid Dose Facility

Tianyin Pharmaceutical announced it received GMP certification for its new solid dosage manufacturing facility from the SFDA. The company said the new facility will triple its solid dose capacity. Tianyin, which has historically concentrated in TCM, has been branching out into generic versions of western drugs....   more»

China Aoxing Pharmaceutical Company, Inc. »17/09/2009 [Company watch]
China Aoxing Receives SFDA Approval for Clinical Trial of Abuse Resistant Opioid Drug

China Aoxing, today announced that its Clinical Trial Application for Tilidine/Naloxone Capsules, an opioid drug with abuse resistance property, was officially approved by the China State Food and Drug Administration. CTA approval is a key SFDA requirement prior to pursuing a clinical trial...   more»

»17/09/2009 [Industry news]
Docs get their threedom- pilots allow MDs to practice at up to 3 locations

The Ministry of Health (MOH) issued the `Notice on Issues Concerning Physicians to Practice at Different Medical Institutions\' September 11 to implement the requirements stipulated in the medical reform, according to   more»

»14/09/2009 [Industry news]
A week of News in the China bio sector

Highlights from a week of activity in the China Bio sector...   more»

»14/09/2009 [Industry news]
Abbott Laboratories Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent

Abbott announced today that the SFDA has approved its XIENCE V® Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease (CAD) - the leading cause of death in China....   more»

Tianjin Institute Of Pharmaceutical Research—Ne »11/09/2009 [Company watch]
Four Tianyin products included in China\'s Essential Drug List

All the drugs in the Essential Drug List will be included in China\'s basic health insurance catalog with a higher reimbursement percentage....   more»

»10/09/2009 [Industry news]
SFDA to raise TCM standards

New drug standards for traditional Chinese medicine (TCM) will become effective July 1, 2010,...   more»

»09/09/2009 [Industry news]
Beike Biotech Adds International Executives to Strengthen Current Technologies and Develop Future Pipeline

Dr. Jiang will spearhead our initiatives to enhance our current technologies and increase their acceptance by the Western scientific community while Dr. Tao will lead a group developing a pipeline of emerging technologies for the coming five to ten years....   more»

»09/09/2009 [Industry news]
China Biologic Products Appoints Director of Research and Development

The company announced that it has appointed Dr. Vincent Yi-Wu Xie to be the Company\'s Director of Research and Development, effective September 1, 2009, to oversee the development of new biologic products covering processes, analytical methods and indications....   more»

»09/09/2009 [Industry news]
PerkinElmer, Inc. Acquires Leading Diagnostics Company in China for About $63.7 Million

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and their environment, today announced it has completed the acquisition of Shanghai-based SYM-BIO Lifescience,...   more»

»09/09/2009 [Industry news]
Cleveland Biolabs Inc. and Zhejiang Hisyn Pharmaceutical Co. Enter License Agreement for Protectan CBLB612 Hematopoietic Stem Cell Stimulator and Mobilizer in China

Under the terms of the license agreement, Cleveland BioLabs will receive upfront product development payments of $1.65 million....   more»

»07/09/2009 [Company watch]
The last week review in China Biotech

A week of action in the China Biotech industry...   more»

»07/09/2009 [Industry news]
China\'s flu victims may double to 10000

More than 100 people across China have been infected with H1N1 flu since Friday, a clear signal the peak season has begun for the potentially deadly virus, Zeng Guang, a senior epidemiologist at the Chinese Center for Disease Control and Prevention, warned Sunday....   more»

»07/09/2009 [Industry news]
MOH releases preliminary new National Formulary draft for comment

The Ministry of Health (MOH) issued the draft of the new National Formulary on its website September 3. The MOH has requested experts to submit their opinions and feedback by September 30....   more»

»07/09/2009 [Industry news]
Benitec Limited Enters Into Binding Agreements For Treatment Of Chronic Hepatitis B Virus

(ABN Newswire) - Benitec Limited has now entered into binding agreements with China based Biomics Biotechnologies Co. Ltd....   more»

»04/09/2009 [Company watch]
China Starts Flu Vaccine Stockpile with Sinovac Order

China has ordered 7.3 million doses of H1N1 (swine) flu vaccine from two domestic manufacturers: 3.3 million does from Sinovac (SVA) and 4 million doses from Hualan Biological Engineering Inc. Both companies received SFDA approval of their vaccines this week. All 7.3 million doses must be delivered by September 15. Financial terms were not disclosed....   more»

»04/09/2009 [Industry news]
20 Guangzhou CROs Form Allinace

Twenty CROs in Guangzhou formed a regional consortium, the Guangzhou Biotech Outsourcing Alliance (GZBO), to promote cooperation among the members. GZBO hopes to build an integrated full-service infrastructure in Guangzhou and coordinate efforts for international business development. GZBO also signed a cooperation agreement with Beijing CROs...   more»

»03/09/2009 [Company watch]
China Aoxing Submits Cough Medicine for Approval

China Aoxing Pharmaceutical Company (CAXG.OB), which specializes in the strictly regulated sector of narcotic and pain medications, has submitted its application for SFDA approval of Codeine Phosphate, an oral solution for the treatment of acute moderate to severe cough. China Aoxing expects to launch this product in China in 2010, assuming the regulatory review goes well....   more»

»03/09/2009 [Independent reports]
China CRO industry booms as pharma demand heats up

Big Pharma needs to cut development spending and boost its presence in big new markets is driving sizzling hot growth rates for China contract research organizations....   more»

»02/09/2009 [Company watch]
Sinopharm Signs Up 9 Cornerstone Investors In $1 Billion IPO Source

China National Pharmaceutical Group Corp. has signed up nine cornerstone investors that will subscribe to a combined US$195 million worth of shares in the company\'s US$1 billion Hong Kong initial public offering, a person familiar with the deal said Tuesday....   more»

»02/09/2009 [Industry news]
Skystar Bio-Pharmaceutical (CGPN) Awarded High Technology Enterprise Certificate

Skystar Bio-Pharmaceutical Company, a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that the Company was awarded a High Technology Enterprise Certificate from the Shaanxi Province Ministry of Science and Technology, Shaanxi Province Ministry of Finance and Shaanxi Province State Administration of Taxation....   more»

»01/09/2009 [Other]
A hospital in Shanghai forgot to operate on a patient

A hospital in Shanghai forgot to operate on a patient after anesthetizing him for 50 minutes, but a surgeon told him that the operation was a success when he woke up,...   more»

»01/09/2009 [Other]
China PMI of manufacturing sector rises to 54% in Aug

The Purchasing Managers Index (PMI) of the China manufacturing sector stood at 54 percent in August, the China Federation of Logistics and Purchasing said Tuesday....   more»

Sundia MediTech Company,Ltd.
»01/09/2009 [Industry news]
Sundia gets the (Highest Growth Potential) award

Sundia MediTech, a pharmaceutical R&D outsourcing company in China, has received the Highest Growth Potential Award from Zhangjiang Hi-Tech Park on August 26....   more»

»01/09/2009 [Industry news]
Sinovac: H1N1 vaccine passes SFDA experts evaluation

Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced that its H1N1 vaccine has passed the experts evaluation organized by State Food and Drug Administration (SFDA), China....   more»

»01/09/2009 [Industry news]
China Medical Technologies Still Stumbling

Over the past few years, China Medical Technologies (NSDQ: CMED) transformed itself from a company focused on a single medical device, the tumor-fighting High Intensity Focused Ultrasound machine, into a business with an attractive portfolio of in vitro diagnostic tests. The process looked seamless. China Medical first bought an ECLIA platform, then a FISH diagnostic system. After each purchase, it built a business around the new platform in a process that seemed both quick and steady. Like many successful initiatives, their growth seemed inevitable – after the fact....   more»

»30/08/2009 [Industry news]
The last week in China

A brief report on activities in the China Bio Industry over the last week...   more»

China Sky One Medical,Inc. »30/08/2009 [Company watch]
China Sky One Admits Under-Reported Revenue

China Sky One Medical admitted that its financial reports filed with the State Administration for Industry and Commerce (SAIC) under-reported the income of China Sky One China-based subsidiaries....   more»

»27/08/2009 [Industry news]
China includes AOBO products in Essential Drug List

Chinese pharma company American Oriental Bioengineering (AOBO) announced that 61 of its products have been included in Chinas Essential Drug List (EDL). AOBO currently manufactures and markets six of the sixty one products,...   more»

»26/08/2009 [Company watch]
China Nepstar reports 7% rise in revenue in Q2 2009

China Nepstar Chain Drugstore, the largest retail drugstore chain in China based on the number of directly operated stores, announced that for the quarter ended June 30, 2009, its revenue stood at $78 million reflecting a 7.5% increase compared to revenue of RMB497 million in the second quarter of 2008 on a pro forma basis....   more»

»24/08/2009 [Industry news]
Pharmaceutical giants eye the booming China market

Domestic and foreign drug companies are competing for business opportunities in the fast-growing China market....   more»

»24/08/2009 [Other]
Beijing tops Hurun rich list with 143,000 millionaires

The latest Hurun Report on the wealthiest people highlights how the super-rich of Beijing want to live their lives. Beijing has the largest number of wealthy people in China, according to the report....   more»

»24/08/2009 [Finance]
China economy to grow 8 pct in 2010

Chinese economic growth is likely to stay at 8 percent next year as property and corporate investment and rising exports take up the slack from waning government investment, central bank adviser Fan Gang said in remarks reported on Monday. (Reuters)...   more»

»24/08/2009 [Industry news]
Lundbeck appoints new manager in China

Lundbeck has appointed Oscar Parra, who most recently held the position as product manager with the Group, as new country manager of Lundbeck subsidiary in China....   more»

»23/08/2009 [Other]
China, U.S. Sign MOU on Energy, Climate Change, Environment Co-op

Zhang Xiaoqiang (L), vice minister of China State Development and Reform Commission, and David Sandalow, assistant secretary of policy and international affairs at the Department of Energy of the United States, sign the energy and environment part of the bilateral Memorandum of Understanding (MOU) in Washinton D.C., July 28, 2009. China and the United States signed the Memorandum of Understanding (MOU) here Tuesday on the cooperation in energy, climate change and environment....   more»

»23/08/2009 [Industry news]
ChinaBio Week

Industry news over the last week...   more»

»21/08/2009 [Company watch]
Sinovac Biotech reports H1 sales growth of 4.7%

Sinovac Biotech, a leading developer and provider of vaccines in China, announced that during the six-months ended June 30, 2009, sales were $26.6 million, up 4.7 percent from $25.4 million for the same period in 2008. Sinovac recorded a strong second quarter, which greatly improved its performance for the year to date....   more»

Simcere Pharmaceutical Group »21/08/2009 [Industry news]
Forty-two of Simcere Pharmaceutical Group Generic Drugs Enter the China Essential Drug List

Simcere Pharmaceutical Group a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that forty-two of its generic drugs have been included in China\'s Essential Drug List, which was issued by China Ministry of Health on August 18, 2009....   more»

»20/08/2009 [Industry news]
Sinopharm, Shanghai Pharma lead new CAPC top 100 pharmaceutical distributor list

The China Association of Pharmaceutical Commerce (CAPC) has released its list of the top 100 pharmaceutical distributors of 2008, Medicine Economic News reported August 20. 500 pharmaceutical distribution companies were included in the selection....   more»

»20/08/2009 [Industry news]
China says new drug policy stirs competition,

* Chinese drug companies jump on news of drug list; * First step in $124.5 billion healthcare reform; * Key to economy moving from export- to consumption-based...   more»

»20/08/2009 [Industry news]
Chindex enters $7 mn CDC contract in China

Chindex International, a US company that provides healthcare services and supplies medical devices to the Chinese market, has entered into a contract to supply $7.12 million in laboratory and hospital products to Centers for Disease Control (CDC) in Qinghai Province....   more»

»19/08/2009 [Industry news]
National Basic Drug list (for grassroots institutions) released by State Council

The State Council released the national basic drug list for grassroots medical institutions (including community and rural clinics) along with the accompanying policy: Administrative Methods for the National Basic Drug List\\\' August 18, according to the central government website,   more»

Pfizer »19/08/2009 [Industry news]
Pfizer bids to recapture Viagra China brand name falls limp

The Supreme Peoples Court of China has rejected Pfizers appeal to turn over a previous ruling regarding Pfizer s brand name rights to its erectile dysfunction (ED) drug Viagra,...   more»

»18/08/2009 [Industry news]
SFDA issues regulated medical devices list

The State Food and Drug Administration (SFDA) issued the `Key Regulated Medical Devices List (2009 version)\' on its website August 17 in order to strengthen the supervision of medical devices....   more»

»18/08/2009 [Industry news]
TCM for hepatic fibrosis starts phase II trials at UCSD School of Medicine

Fuzheng Huayu tablet, a traditional Chinese medicine (TCM) for the treatment of hepatic fibrosis in patients with hepatitis C, has received approval from the Institutional Review Board (IRB) of the University of California, San Diego School of Medicine to conduct clinical trials...   more»

»18/08/2009 [Industry news]
Sinovac Flu Vaccine effective after just one shot

Until now, experts have predicted that two shots will be needed to provide swine flu immunity....   more»

China Biopharmaceuticals Holdings »18/08/2009 [Company watch]
China Pharma Holdings, Inc. Announces SFDA Approval for Production of Omeprazole Injections

Omeprazole is widely utilized to treat gastroesophageal reflux disease (GERD), and is highly effective in other conditions caused by excess acidic formulations in the stomach, including gastric ulcers, recurrent duodenal ulcers and Zollinger-Ellison Syndrome....   more»

»18/08/2009 [Industry news]
Diagnostic Devices Unique (Made in U.S.A) Formula is Bringing 200 Jobs Back to U.S. from China

Diagnostic Devices, Inc. (DDI), the maker of Prodigy® blood glucose monitoring systems, and the leading provider of audible meters, is leading what could be a made-in-America revolution by doing the unthinkable and bringing manufacturing jobs home from China, according to experts in international trade....   more»

»17/08/2009 [Industry news]
See New Event 7/8 September

See under Events Listing...   more»

»17/08/2009 [Industry news]
Welch Allyn and Guangzhou Medical College Establish Training Center for General Practice Medicine

Guangzhou General Practice Skill Training Center is the Second Step in Welch Allyn Helping Further Chinese Initiative to Improve Community Health Care...   more»

»17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services

With a pair of small hospitals in Beijing and Shanghai, along with a clinic in Guangzhou, Chindex International sells its well-heeled clientele a more attentive experience than that offered by China state-run hospitals....   more»

»17/08/2009 [Other]
China Stocks Drop Most in 9 Months, Led by Commodity Suppliers

China benchmark stock index fell the most in nine months as foreign direct investment plunged, Ping An Insurance (Group) Co. profit missed estimates and Yunnan Copper Industry Co. said there are no clear signs of a recovery....   more»

»17/08/2009 [Industry news]
Private cord blood bank CordLife has gained foothold in China

Private cord blood bank CordLife has gained foothold in China after signing an agreement with the countrys largest cord blood bank, Beijing China Cord Blood Bank....   more»

»17/08/2009 [Industry news]
BioTek appoints Mr. Danny Luo as GM of China operations

BioTek Instruments, Inc., a global player in the development, manufacture and sale of microplate instrumentation for drug discovery and life science solutions, has named Mr. Danny Luo as General Manager of its China office....   more»

»16/08/2009 [Industry news]
China Biotech Review:

A week of action in the China Bio industry...   more»

»03/08/2009 [Independent reports]
BioSpectrumAsia Top 20 Vol. 2: Asia Life Sciences Industry employs 2.3 mn People

An independent look at how labour is deployed within the sector...   more»

»03/08/2009 [Industry news]
China pharmaceutical market primed to explode

China s ambitious $124 billion effort to provide basic health coverage for the vast majority of its 1.3 billion citizens by 2011 is a brimming opportunity for large global drugmakers....   more»

»03/08/2009 [Other]
Plague Kills 2 Men in Remote China; Town Quarantined

(Bloomberg) -- A second man died of pneumonic plague in a remote area of northwestern China as officials quarantined a town to stop the pneumonia-causing disease spreading...   more»

»03/08/2009 [Other]
China manufacturing expanded in July as record lending and a 4 trillion yuan ($585 billion) stimulus package stoked a recovery in the worlds fastest- growing major economy.

The CLSA China Purchasing Managers Index rose to a seasonally adjusted 52.8, the highest level in a year, from 51.8 in June, CLSA Asia-Pacific Markets said today in an e-mailed statement. An official index, released Aug. 1, also expanded....   more»

»03/08/2009 [Other]
NEW EVENTS Sept/Nov/Dec 09

See Events Listing...   more»

»02/08/2009 [Industry news]
Dabur Pharma eyes China & Japan entry

Domestic anti-cancer drug major Dabur Pharma is finalising plans to enter Japan and China. The company has started the groundwork of filing drug applications and is scouting for potential pharma acquisitions in both the countries....   more»

Covance »31/07/2009 [Company watch]
Covance Becomes First CRO to Globally Deliver Innovative Technique for TK/PK Sampling

Covance Inc. today announced the addition of a new global integrated service supporting the Dried Blood Spot (DBS) sampling technique with Good Laboratory Practice (GLP) toxicology and bioanalytical analysis. Conforming to the three R\'s guiding principles of research — reduction, replacement, and refinement — DBS sampling provides higher quality toxicokinetic data while reducing test article, shipping, and storage requirements....   more»

Lotus Pharmaceuticals »31/07/2009 [Company watch]
Lotus Receives Diabetes Drug Patent

Lotus Pharmaceuticals has received a patent pending notice from China Intellectual Property Office for Gliclazide-Controlled Release Tablets, a controlled release form of the hypoglycemic drug gliclazide that is aimed at type 2 diabetes....   more»

»30/07/2009 [Company watch]
China Medical Technologies, Inc. Announces the Substantial Completion of an Independent Internal Investigation

Company Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited Financial Results for the Quarter and Fiscal Year ended March 31, 2009 and the Quarter ended June 30, 2009...   more»

»30/07/2009 [Company watch]
Pfizer, Fudan University ally for clinical research training

Healthcare major Pfizer is partnering with Fudan University of China to establish a graduate program in Clinical Data Management and Statistical Programming. This three year Masters Degree program, a first of its kind in China, is designed to develop qualified professionals to support clinical research which is rapidly increasing in China....   more»

Charles River
»28/07/2009 [Company watch]
Charles River Shanghai Achieves Accreditation Milestone

On the heels of its grand opening in October, the Charles River preclinical facility in Shanghai has been awarded Shanghai Laboratory Animal Commission (SLAC) Accreditation and full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC)....   more»

»28/07/2009 [Industry news]
aTyr Pharma Raises an Additional $12 Million

Investors add $12 M to Expand Discovery and Development of a New Class of Protein Therapeutics...   more»

»27/07/2009 [Other]
Sinochem Confirms Early-Stage Talks Over Nufarm Deal

(Bloomberg) -- Sinochem Corp. confirmed it is in early stage talks for a potential takeover of Nufarm Ltd., marking Chinas second attempt in as many years to buy Australias biggest supplier of farm chemicals....   more»

»27/07/2009 [Other]
Chinese shares rise for 4th consecutive day to nearly 14-month high

(Xinhua) -- Chinese equities closed higher for the fourth consecutive day on Monday to a nearly 14-month high, after investors were reassured the country would continue its proactive fiscal policy to maintain economic growth....   more»

»27/07/2009 [Industry news]
Biotech in Review

A week of activities in the China bio industry...   more»

Johnson & Johnson
»26/07/2009 [Company watch]
J&J Wins Approval to Market MDS Drug Without China Trials

Xian-Janssen, a division of Johnson & Johnson has launched a new drug in China. Dacogen (decitabine), a novel treatment for myelodysplastic syndrome, received SFDA approval through the Green Channel, an expedited approval process that the SFDA introduced in January 2009....   more»

GlaxoSmithKline »24/07/2009 [Company watch]
GSK to Distribute Dr. Reddys Generics in Emerging Markets

GlaxoSmithKline has partnered up with Dr. Reddys Laboratories in a deal that will allow GSK to sell Dr. Reddys generic pharmaceutical products in emerging markets. The targeted countries include China, though Dr. Reddys home market of India is excluded....   more»

»24/07/2009 [Industry news]
China Medical Device Industry: Growing Market, New Regulations Fuel Competition

Looking to address shortfalls in its current health care system, the Chinese government is implementing large-scale health care reforms....   more»

»24/07/2009 [Industry news]
Dawn of a new era for drug tenders? Guangdong begins Sunshine Procurement System

Guangdong Provinces Sunshine Procurement System (an online drug procurement platform) came into effect recently after several months of soliciting public feedback, according to Xiaojun Huang of the Ministry of Health (MOH)....   more»

»24/07/2009 [Industry news]
China outlines plans on health care reform in 2009

(Xinhua) -- China State Council Thursday issued a medical reform plan of 2009, as its first year move of the three-year health care reform....   more»

»24/07/2009 [Company watch]
AlphaRx Inc. (ALRX) Signs Cooperation Agreement with Venturepharm China

ChinaBio Today -- AlphaRx and Venturepharm China, a subsidiary of Venturepharm Laboratories Ltd., recently entered into a cooperation agreement. Venturepharm will provide AlphaRx with research services for its vaccine and anti-cancer drugs. Venturepharm will also help AlphaRx develop adjuvant vaccines for swine flu (A/H1N1)....   more»

Wuxi Pharma Tech
»23/07/2009 [Company watch]
WuXi names Dr Chi-Chung Chan as VP Pharmacology

WuXi PharmaTech, a life science outsourcing company with operations in China and the US, appointed Dr Chi-Chung Chan as Vice President of Pharmacology....   more»

»23/07/2009 [Industry news]
SIMM awarded China patent for diabetes combination TCM extract

The Shanghai Institute of Materia Medica (SIMM) recently received a national patent for a traditional Chinese (TCM) medicine drug combination used for treatment of diabetes, according to the Chinese Academy of Sciences (CAS)...   more»

»23/07/2009 [Industry news]
Chinese experts grow live mice from skin cells

(Reuters) - Chinese researchers have managed to create powerful stem cells from mouse skin and used these to generate fertile live mouse pups....   more»

China Aoxing Pharmaceutical Company, Inc. »23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products

China Aoxing Pharmaceutical Company, Inc., a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that it has received renewal of the Good Manufacturing Practice (GMP) certification for its capsule formulation and packaging production facility....   more»

»21/07/2009 [Industry news]
American Oriental Bioengineering, Elected a Top 20 Most Competitive Public Pharmaceutical Company in China

American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China, today announced that AOBO was honorably elected as one of the Top 20 Most Competitive Public Pharmaceutical Companies in China....   more»

»21/07/2009 [Company watch]
AlphaRx Inc. Unveils its China Strategy

AlphaRx , an emerging biopharmaceutical company, utilizing proprietary drug delivery technology to develop novel formulations of drugs, is forging ahead with its growth strategy for Greater China. As part of this strategy, AlphaRx is poised to open a (state of the art) R D and pilot plant facility in China with local partners....   more»

»20/07/2009 [Industry news]
Work begins on China s first heavy ion therapy center for cancer patients

Construction has begun on Chinas first hospital focusing on heavy ion therapy for cancer sufferers in Lanzhou, capital of the northwestern Gansu Province....   more»

»20/07/2009 [Industry news]
Gastric Cancer Breakthrough

China has developed the worlds first oral vaccine for Helicobacter pylori (HP), a bacterium closely linked to gastric cancer...   more»

»20/07/2009 [Industry news]
New Vaccine against H5N1 Bird Flu Virus

Scientists from the Department of Microbiology at the University of Hong Kong and the US National Institute of Health (NIH) have developed a H5N1 bird flu vaccine by piggybacking it on the well-tested and highly successful smallpox vaccine...   more»

Sundia MediTech Company,Ltd.
»20/07/2009 [Company watch]
Sundia in Top 100 Fast-growth Outsourcing Companies in China

Sundia MediTech Company, a leading pharmaceutical R&D outsourcing service company in China, announced today that the company was named as a Top 100 Fast-growth Outsourcing Service Provider. This selection was jointly sponsored by China Council for International Investment Promotion (CCIIP) and three global leading market researchers, TPI, IDC and Gartner....   more»

»19/07/2009 [Industry news]
A Week in the China Life Sciences Industry

Moves and announcements in the past week...   more»

»18/07/2009 [Industry news]
China medicine watchdog launches pharmaceutical safety program

The China State Food and Drug Administration (SFDA) has announced a two-year campaign to improve the quality standards of pharmaceuticals from manufacture to sale....   more»

»17/07/2009 [Industry news]
New draft GMP guidelines completed, software/SOPs a focus

The review and evaluation of the draft of the new Good Manufacturing Practice (GMP) guidelines has been completed and will be sent to the State Council for approval, according to an expert from the State Food and Drug Administration (SFDA)...   more»

»17/07/2009 [Industry news]
Biostar Pharma Wins Approval for Three New TCM Products

by: ChinaBio Today Biostar Pharmaceuticals, Inc. received local approval for three TCM products, which it expects to begin selling later this month. The company projects a total of $3.5 million in revenues from the three products in 2009, and $7.4 million in 2010. Biostar anticipates they will produce net income of $1 million this year and $2 million in 2010....   more»

»17/07/2009 [Industry news]
Novartis AG to Offer Management BiMBA in China

In Beijing, Novartis has established a Sino-European Novartis University of China...   more»

»16/07/2009 [Industry news]
China Biologic Products Hosts its First Forum for Strategy and Development

China Biologic Products, Inc. one of the leading plasma-based pharmaceutical companies in China, today announced that the Company hosted a forum of industry experts on July 10 - 11, 2009, at its headquarters in Taian, Shandong Province, to discuss future development strategies for the Company....   more»

»16/07/2009 [Industry news]
China Medicine Corporation Receives rADTZ Feasibility Report from the Feed Research Institute

China Medicine Corporation, a leading distributor and developer of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines, nutritional and dietary-supplements, medical devices, and medical formulations in China, announced today that it has received a third party feasibility report on recombinant Aflatoxin Detoxifizyme (rADTZ) from the Feed Research Institute (FRI) of the Chinese Academy of Agricultural Sciences (CAAS)....   more»

China Sky One Medical,Inc. »14/07/2009 [Company watch]
China Sky One Medical, Inc. Obtains Renewal of GMP Certificate

The company today announced that its Peng Lai Jin Chuang Pharmaceutical Company subsidiary obtained a renewal of its Good Manufacturing Practices Certificate for Pharmaceutical Products (GMP)...   more»

»14/07/2009 [Industry news]
Benitec Limited Signs Memorandum Of Understanding With Biomics Biotechnologies Co. Ltd In China

The companies will collaborate on a DNA directed or vector expressed RNAi for the treatment of chronic hepatitis B virus (HBV) infection....   more»

»14/07/2009 [Other]
China bans electro-shock therapy for Internet addicts

(Reuters) - China has banned electro-shock therapy as a treatment for Internet addiction, citing uncertainty in the safety and effectiveness of the practice after criticism in the local media....   more»

Bayer »13/07/2009 [Industry news]
Scigen signs insulin deal with Bayer in China

Singapore-based biotechnology company, SciGen and its Polish holding company, Bioton have signed an exclusive insulin supply and distribution agreement with Bayer Schering Pharma, in China....   more»

»13/07/2009 [Industry news]
NovaMed expands cardio, oncology pipelines in China

NovaMed Pharmaceuticals has signed two new agreements with Iroko and EUSA Pharma, both of which significantly reinforce NovaMeds position in two strategic therapy areas - cardiovascular and oncology....   more»

»13/07/2009 [Industry news]
Last week in Review

Activities in the China Bio industry in the last week...   more»

»13/07/2009 [Industry news]
Government, corporate sector to shoulder greater healthcare expenditure burden

By the year 2014, payment of Chinas total healthcare expenditure is expected to be 30% from the government, 40% from the corporate sector, and 30% from individuals,...   more»

»10/07/2009 [Other]
Espionage Charges in China May Be Linked to Negotiations Over Iron Ore Prices

China s detention of four employees of the Anglo-Australian mining giant Rio Tinto on spying charges this week is tied to evidence that they obtained confidential state documents during negotiations with Chinese steel makers over iron ore prices, people with direct knowledge of the case said Friday....   more»

»09/07/2009 [Industry news]
Executive hiring in Asia better but still slow -survey

(Reuters) - Job prospects for executives in Asia have improved in the past three months as employers expect business to pick up later in the year, although they are still cautious about adding headcount, a survey showed. In healthcare and life sciences, 38 percent of firms plan to hire for a third straight quarter....   more»

»08/07/2009 [Industry news]
Perot Systems Corporation Selected to Implement Health Information Systems in China

The Hunan Provincial Government of the Peoples Republic of China that will authorize the company to provide IT consulting services for healthcare organizations and public health initiatives throughout the Province....   more»

»07/07/2009 [Industry news]
Experts Discuss Potential of Partnering in China at the ChinaBio® Partnering Forum

A frank look at co-operation debated by leading industry figures...   more»

Sundia MediTech Company,Ltd. »07/07/2009 [Company watch]
Sundia acquires PFSC technology

Sundia MediTech, an integrated pharmaceutical and biotech R&D outsourcing company in Shanghai, China has acquired Protein Folding Shape Code (PFSC) technology for doing probe binding site for drug discovery from Microtech Nano, a R&D company in Indianapolis, US. As part of this business deal, Dr Jiaan Yang, the founder and President of Microtech Nano joins Sundia as Vice President of Drug Discovery Technology....   more»

»07/07/2009 [Industry news]
Tamiflu resistant swine flu virus detected in HK

The Department of Health, Hong Kong, late last week said that the Public Health Laboratory Services Branch (PHLSB) has detected a strain of human swine influenza (HSI) virus which was resistant to oseltamivir (Tamiflu)....   more»

Sundia MediTech Company,Ltd. »06/07/2009 [Industry news]
Dr Chen joins Sundia chemistry services team

Sundia MediTech, an integrated pharmaceutical and biotech R&D outsourcing company in Shanghai, China, has appointed Dr Chen Chen as the Senior Vice President of Chemistry Services....   more»

»06/07/2009 [Finance]
Shanghai Companies Sign First Yuan Settlement Deals

Three Shanghai companies agreed to settle import and export contracts in yuan for the first time, as China seeks to reduce the role of the dollar in global trade....   more»

»06/07/2009 [Industry news]
A Review of the past week in the China Bio Industry

Chinabio Today: what\'s been happening throughout the market....   more»

»06/07/2009 [Industry news]
China governments ordered to spend more on health care

China central government has ordered local governments to increase funding for public health care system, the Ministry of Finance said in a statement on its website Sunday....   more»

»06/07/2009 [Industry news]
Beijing spends 10 mln yuan to encourage TCM in cure of A/H1N1

The Beijing municipal government has allocated 10 million yuan (about 1.46 million U.S. dollars) to support the use of traditional Chinese medicine (TCM) in treating the A/H1N1 influenza, the Beijing Administration Bureau of TCM (BJTCM) confirmed to Xinhua Monday....   more»

»05/07/2009 [Industry news]
NeoStem Raises an Additional $4 Million

by: ChinaBio Today July 05NeoStem, Inc. (NBS) has raised another $4 million from institutional and private investors. The terms of the funding were the same as those for the companys previous fund raising, an $11 million private placement in April involving three Asia-based investors....   more»

Wuxi Pharma Tech
»03/07/2009 [Company watch]
WuXi PharmaTech receives award from BASF

WuXi PharmaTech. received an award from BASF for excellent service and outstanding contributions in the area of custom synthesis for new crop-protection active ingredients....   more»

»03/07/2009 [Industry news]
Winner Medical signs sales pact with consumer products firm in China

Winner Medical Group, a leading manufacturer in the medical dressing industry (medical and wound care products) in China has signed an agreement with a leading consumer products company in China to provide PurCotton rolls....   more»

»03/07/2009 [Independent reports]
Foreign Pharmas Marching into Chinese Towns

While entry of multinational pharmaceutical companies into China has greatly improved the technologies, products and management of the country healthcare industry, it also causes significant impacts on Chinas own pharmaceutical industry. Foreign pharmaceutical companies are now gaining more and more market, equity and technology power in China, and furthermore, the new drugs market of China is now basically controlled by foreign players....   more»

»02/07/2009 [Industry news]
ChemWerth, Inc. announces Wuhan Pharmaceutical Factory passes FDA inspection

02 Jul 2009 - ChemWerth Inc. reported the Wuhan Pharmaceutical Factory facility has passed an FDA overseas inspection with a two point 483 being issued....   more»

»01/07/2009 [Industry news]
Bio-Bridge Science, Inc. Subsidiary Acquires a Raw Bovine Serum Collection Centre

Bio-Bridge Science, Inc., announced it had finished acquiring a raw bovine serum collection center in Beian City, Heilongjiang Province, China by purchasing serum production equipment at the facility....   more»

»01/07/2009 [Industry news]
Abbreviated basic drug list to be released,

Abbreviated basic drug list to be released, full version expected in August...   more»

»01/07/2009 [Company watch]
Bayer Launches New Anti-Clotting Drug in China

Bayer Healthcare has launched its new anti-clotting drug Xarelto (rivaroxaban) in China following SFDA approval....   more»

»01/07/2009 []
Biosimilar market growth depends on the US: DataMonitor

A report by Datamonitor...   more»

GlaxoSmithKline »29/06/2009 [Company watch]
GSK says Asia Pacific sales could double in 5 yrs

(Reuters) - British drugmaker GlaxoSmithKline said its Asia-Pacific sales could double in five years as growing prosperity boosts demand for better healthcare and as it cuts prices in some Asian countries....   more»

»29/06/2009 [Other]
see New Event July 09

...   more»

Wuxi Pharma Tech »29/06/2009 [Company watch]
WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise

WuXi PharmaTech announced today that it had been selected by China Ministry of Commerce to the list of Top Ten Leading Outsourcing Enterprises in China....   more»

»28/06/2009 [Finance]
Sanjin Seeks $133 Million in First China IPO in 2009

Guilin Sanjin Pharmaceutical Co., biggest producer of herbal lozenges in China, plans to raise 910.8 million yuan ($133 million) in the nation’s first initial public offering since September....   more»

Sundia MediTech Company,Ltd. »28/06/2009 [Industry news]
Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai

Shanghai Pudong Customs, Pudong International Airport Customs and Zhangjiang Group Co. held ceremony in the Zhangjiang Hi-Tech Park to initiate the Express Customs Clearance for 3 biopharmaceutical R&D outsourcing (CRO) companies....   more»

»28/06/2009 [Industry news]
Hong Kong lays firm foundation in biotechnology and nanotechnology

Hong Kong had laid a firm foundation for developing biotechnology and nanotechnology in the years to come and the Government would continue its investments in both fostering stronger research and nurturing a thriving industry, Assistant Commissioner for Innovation and Technology, Mr Nicholas Chan said...   more»

»27/06/2009 [Other]
China Restricts Residents Access to Health Care Web Sites

China Ministry of Health published a new set of regulations that limit access to online medical information, particularly sites that discuss sexual health, the Wall Street Journal China Journal reports....   more»

»26/06/2009 [Industry news]
Skystar Bio-Pharmaceutical Begins Trading on NASDAQ Capital Market

Skystar Bio-Pharmaceutical Co., Ltd., a leading China-based producer and distributor of veterinary medicines, vaccines, microorganisms and feed additives, announced that its common stock will begin trading on the NASDAQ Capital Market under the symbol SKBI, effective at the open of trading today, June 26, 2009....   more»

»25/06/2009 [Industry news]
Medical reform detrimental to retail pharmacies?

China medical reform will halt the development of retail pharmacies, said Jingxia Wang, president of the Chain Pharmacy Branch of the China Association of Pharmaceutical Commerce....   more»

China Biopharmaceuticals Holdings »24/06/2009 [Company watch]
China Pharma Wins OK for Generic Cholesterol Drug Trials

China Pharma Holdings (CPHI.OB) obtained approval from the SFDA to begin Phase I and Phase II clinical trials of Rosuvastatin...   more»

»24/06/2009 [Industry news]
ChinaTrials Summit Announces 75 Global Pharma and Biotech Speakers to Present at Largest China Clinical Development Conference

Over 75 global pharma and biotech experts will present at the annual ChinaTrials: Global Clinical Development Conference & Exhibition in Beijing this November 8-10, as the global biopharmaceutical industry continues to shift its development activities to emerging regions to fuel the next phase of growth....   more»

Wuxi Pharma Tech
»23/06/2009 [Industry news]
WuXi AppTec appoints new senior vice president with device industry pedigree

Hsu will be primarily responsible for WuXi US business....   more»

»23/06/2009 [Industry news]
US Pharmacopeia signs agreements with China counterpart and local drug agencies

The US Pharmacopeial (USP) Convention, a non-profit food and drug standards-setting organization, formed cooperative agreements with three Chinese drug control agencies last week, according to a June 19 report from PRNewswire Asia....   more»

»22/06/2009 [Industry news]
A Review of the Past Week

A week\'s activities in brief...   more»

»22/06/2009 [Other]
They Shoot Frequent Fliers, Don’t They? Only in Chinas Flu Era

By Simeon Bennett (Bloomberg) -- Moments after the plane carrying Erica Eden from New York to Shanghai lands, a team wearing face masks, gloves and white protective suits gets on board and points infrared thermometers at passengers’ heads. Welcome to China in the era of swine flu....   more»

»22/06/2009 [Company watch]
Pfizer aims for No.1 spot

Pfizer will use acquisitions and partnerships in an effort to become the number one drug seller in emerging markets such as China....   more»

»22/06/2009 [Industry news]
DHL boost life science space in Shanghai

DHL has opened a new life sciences facility at Shanghai Pudong airport, taking its temperature controlled warehouse space in the mainland city to 30,000 sq ft....   more»

»19/06/2009 [Industry news]
Tianyin Projects Positive 2009

Tianyin Pharmaceutical Co announced it expects to report revenues of $42 million and net income of $7.5 million in its 2009 fiscal year. Both numbers reflect an increase of 25% over year earlier results....   more»

»17/06/2009 [Company watch]
Venturepharm NASDAQ Flagship Commonwealth Biotechnologies, Inc. Announces Agreement to Acquire Largest Peptide Biotech Company in China

Venturepharm is pleased to inform that its NASDAQ flagship company, Commonwealth Biotechnologies, Inc, has executed an agreement to acquire all of the outstanding shares of a privately owned Shanghai-based chemical company...   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.